PD Review References for 2005:

1: Heffernan C, Jenkinson C.
Measuring outcomes for neurological disorders: a review of disease-specific
health status instruments for three degenerative neurological conditions.
Chronic Illn. 2005 Jun;1(2):131-42. Review.
PMID: 17136919 [PubMed - indexed for MEDLINE]

2: von Bohlen Und Halbach O.
Modeling neurodegenerative diseases in vivo review.
Neurodegener Dis. 2005;2(6):313-20. Review.
PMID: 16909014 [PubMed - indexed for MEDLINE]

3: Rubinsztein DC, DiFiglia M, Heintz N, Nixon RA, Qin ZH, Ravikumar B, Stefanis
L, Tolkovsky A.
Autophagy and its possible roles in nervous system diseases, damage and repair.
Autophagy. 2005 Apr;1(1):11-22. Epub 2005 Apr 30. Review.
PMID: 16874045 [PubMed - indexed for MEDLINE]

4: Shults CW, Haas R.
Clinical trials of coenzyme Q10 in neurological disorders.
Biofactors. 2005;25(1-4):117-26. Review. No abstract available.
PMID: 16873936 [PubMed - indexed for MEDLINE]

5: Seltzer B.
Donepezil: a review.
Expert Opin Drug Metab Toxicol. 2005 Oct;1(3):527-36. Review.
PMID: 16863459 [PubMed - indexed for MEDLINE]

6: Jonderko G, Marcisz C.
[Music application in the therapy of psychic and somatic diseases]
Pol Arch Med Wewn. 2005 Aug;114(2):808-12. Review. Polish. No abstract available.
PMID: 16808321 [PubMed - indexed for MEDLINE]

7: Chan CS, Surmeier DJ, Yung WH.
Striatal information signaling and integration in globus pallidus: timing
matters.
Neurosignals. 2005;14(6):281-9. Review.
PMID: 16772731 [PubMed - indexed for MEDLINE]

8: Fernández-Ruiz J, Gonzáles S.
Cannabinoid control of motor function at the basal ganglia.
Handb Exp Pharmacol. 2005;(168):479-507. Review.
PMID: 16596785 [PubMed - indexed for MEDLINE]

9: Riddle EL, Fleckenstein AE, Hanson GR.
Role of monoamine transporters in mediating psychostimulant effects.
AAPS J. 2005 Dec 20;7(4):E847-51. Review.
PMID: 16594636 [PubMed - indexed for MEDLINE]

10: Riljak V, Langmeier M.
Nicotine an efficient tool of the neurobiological research today, the tool of
treatment tomorrow?
Prague Med Rep. 2005;106(4):329-48. Review.
PMID: 16572927 [PubMed - indexed for MEDLINE]

11: Zhang J, Goodlett DR, Montine TJ.
Proteomic biomarker discovery in cerebrospinal fluid for neurodegenerative
diseases.
J Alzheimers Dis. 2005;8(4):377-86. Review.
PMID: 16556969 [PubMed - indexed for MEDLINE]

12: Meredith SC.
Protein denaturation and aggregation: Cellular responses to denatured and
aggregated proteins.
Ann N Y Acad Sci. 2005 Dec;1066:181-221. Review.
PMID: 16533927 [PubMed - indexed for MEDLINE]

13: Eslamboli A.
Assessment of GDNF in primate models of Parkinson's disease: comparison with
human studies.
Rev Neurosci. 2005;16(4):303-10. Review.
PMID: 16519007 [PubMed - indexed for MEDLINE]

14: McMillan G.
Is electric arc welding linked to manganism or Parkinson's disease?
Toxicol Rev. 2005;24(4):237-57. Review.
PMID: 16499406 [PubMed - indexed for MEDLINE]

15: Rajna P, Hidasi Z, Waldemar S.
[Event-related EEG and evoked potential investigations in clinical practice]
Ideggyogy Sz. 2005 Nov 20;58(11-12):380-92. Review. Hungarian.
PMID: 16491563 [PubMed - indexed for MEDLINE]

16: Alavijeh MS, Chishty M, Qaiser MZ, Palmer AM.
Drug metabolism and pharmacokinetics, the blood-brain barrier, and central
nervous system drug discovery.
NeuroRx. 2005 Oct;2(4):554-71. Review.
PMID: 16489365 [PubMed - indexed for MEDLINE]

17: Silva JL, Cordeiro Y, Foguel D.
Protein folding and aggregation: two sides of the same coin in the condensation
of proteins revealed by pressure studies.
Biochim Biophys Acta. 2006 Mar;1764(3):443-51. Epub 2005 Dec 19. Review.
PMID: 16480935 [PubMed - indexed for MEDLINE]

18: Valdimarsdottir G, Mummery C.
Functions of the TGFbeta superfamily in human embryonic stem cells.
APMIS. 2005 Nov-Dec;113(11-12):773-89. Review.
PMID: 16480449 [PubMed - indexed for MEDLINE]

19: Chiba T, Tanaka K.
[Regulation of the protein degradation pathway by the ubiquitin family: its
implication in neurodegenerative diseases]
Rinsho Shinkeigaku. 2005 Nov;45(11):976-8. Review. Japanese.
PMID: 16447778 [PubMed - indexed for MEDLINE]

20: Muramatsu S.
[Gene therapy and cell transplantation for Parkinson's disease]
Rinsho Shinkeigaku. 2005 Nov;45(11):902-4. Review. Japanese.
PMID: 16447758 [PubMed - indexed for MEDLINE]

21: Iwatsubo T, Ito G, Takatori S, Hannno Y, Kuwahara T.
[Pathogenesis of Parkinson's disease: implications from familial Parkinson's
disease]
Rinsho Shinkeigaku. 2005 Nov;45(11):899-901. Review. Japanese.
PMID: 16447757 [PubMed - indexed for MEDLINE]

22: Dezawa M.
[Future views and challenges to the peripheral nerve regeneration by cell based
therapy]
Rinsho Shinkeigaku. 2005 Nov;45(11):877-9. Review. Japanese.
PMID: 16447751 [PubMed - indexed for MEDLINE]

23: Muramatsu S.
[Gene therapy for Parkinson's disease]
Nippon Rinsho. 2005 Dec;63 Suppl 12:622-5. Review. Japanese. No abstract
available.
PMID: 16416863 [PubMed - indexed for MEDLINE]

24: Wojtera M, Sikorska B, Sobow T, Liberski PP.
Microglial cells in neurodegenerative disorders.
Folia Neuropathol. 2005;43(4):311-21. Review.
PMID: 16416395 [PubMed - indexed for MEDLINE]

25: Ingelsson M, Nilsson L, Basun H, Aquilonius SM, Lannfelt L.
[Conformationally altered proteins cause neurodegenerative diseases]
Lakartidningen. 2005 Nov 21-27;102(47):3542-3, 3545-6, 3549 passim. Review.
Swedish.
PMID: 16408392 [PubMed - indexed for MEDLINE]

26: Acton PD, Zhou R.
Imaging reporter genes for cell tracking with PET and SPECT.
Q J Nucl Med Mol Imaging. 2005 Dec;49(4):349-60. Review.
PMID: 16407818 [PubMed - indexed for MEDLINE]

27: Drake DF, Harkins S, Qutubuddin A.
Pain in Parkinson's disease: pathology to treatment, medication to deep brain
stimulation.
NeuroRehabilitation. 2005;20(4):335-41. Review.
PMID: 16403999 [PubMed - indexed for MEDLINE]

28: Weiner WJ.
A differential diagnosis of Parkinsonism.
Rev Neurol Dis. 2005 Summer;2(3):124-31. Review.
PMID: 16400311 [PubMed - indexed for MEDLINE]

29: Marchetti B, Serra PA, L'Episcopo F, Tirolo C, Caniglia S, Testa N, Cioni S,
Gennuso F, Rocchitta G, Desole MS, Mazzarino MC, Miele E, Morale MC.
Hormones are key actors in gene x environment interactions programming the
vulnerability to Parkinson's disease: glia as a common final pathway.
Ann N Y Acad Sci. 2005 Dec;1057:296-318. Review.
PMID: 16399902 [PubMed - indexed for MEDLINE]

30: Fleming SM, Fernagut PO, Chesselet MF.
Genetic mouse models of parkinsonism: strengths and limitations.
NeuroRx. 2005 Jul;2(3):495-503. Review.
PMID: 16389313 [PubMed - indexed for MEDLINE]

31: Bové J, Prou D, Perier C, Przedborski S.
Toxin-induced models of Parkinson's disease.
NeuroRx. 2005 Jul;2(3):484-94. Review.
PMID: 16389312 [PubMed - indexed for MEDLINE]

32: Sang TK, Jackson GR.
Drosophila models of neurodegenerative disease.
NeuroRx. 2005 Jul;2(3):438-46. Review.
PMID: 16389307 [PubMed - indexed for MEDLINE]

33: Pertovaara A, Haapalinna A, Sirviö J, Virtanen R.
Pharmacological properties, central nervous system effects, and potential
therapeutic applications of atipamezole, a selective alpha2-adrenoceptor
antagonist.
CNS Drug Rev. 2005 Autumn;11(3):273-88. Review.
PMID: 16389294 [PubMed - indexed for MEDLINE]

34: Jost WH, Angersbach D.
Ropinirole, a non-ergoline dopamine agonist.
CNS Drug Rev. 2005 Autumn;11(3):253-72. Review.
PMID: 16389293 [PubMed - indexed for MEDLINE]

35: Kulkarni AP, Kellaway LA, Kotwal GJ.
Herbal complement inhibitors in the treatment of neuroinflammation: future
strategy for neuroprotection.
Ann N Y Acad Sci. 2005 Nov;1056:413-29. Review.
PMID: 16387706 [PubMed - indexed for MEDLINE]

36: Cohen S, Freedman M.
Cognitive and behavioral changes in the Parkinson-plus syndromes.
Adv Neurol. 2005;96:166-86. Review. No abstract available.
PMID: 16383219 [PubMed - indexed for MEDLINE]

37: Voon V, Moro E, Saint-Cyr JA, Lozano AM, Lang AE.
Psychiatric symptoms following surgery for Parkinson's disease with an emphasis
on subthalamic stimulation.
Adv Neurol. 2005;96:130-47. Review.
PMID: 16383217 [PubMed - indexed for MEDLINE]

38: Hui JS, Murdock GA, Chung JS, Lew MF.
Behavioral changes as side effects of medication treatment for Parkinson's
disease.
Adv Neurol. 2005;96:114-29. Review. No abstract available.
PMID: 16383216 [PubMed - indexed for MEDLINE]

39: Rippon GA, Marder KS.
Dementia in Parkinson's disease.
Adv Neurol. 2005;96:95-113. Review.
PMID: 16383215 [PubMed - indexed for MEDLINE]

40: Levin BE, Katzen HL.
Early cognitive changes and nondementing behavioral abnormalities in Parkinson's
disease.
Adv Neurol. 2005;96:84-94. Review.
PMID: 16383214 [PubMed - indexed for MEDLINE]

41: Groves MS, Forrest DV.
Parkinson's disease as a model for psychosocial issues in chronic
neurodegenerative disease.
Adv Neurol. 2005;96:65-83. Review.
PMID: 16383213 [PubMed - indexed for MEDLINE]

42: Aarsland D, Alves G, Larsen JP.
Disorders of motivation, sexual conduct, and sleep in Parkinson's disease.
Adv Neurol. 2005;96:56-64. Review.
PMID: 16383212 [PubMed - indexed for MEDLINE]

43: Richard IH.
Anxiety disorders in Parkinson's disease.
Adv Neurol. 2005;96:42-55. Review.
PMID: 16383211 [PubMed - indexed for MEDLINE]

44: Mentis MJ, Delalot D.
Depression in Parkinson's disease.
Adv Neurol. 2005;96:26-41. Review.
PMID: 16383210 [PubMed - indexed for MEDLINE]

45: Saint-Cyr JA.
Basal ganglia: functional perspectives and behavioral domains.
Adv Neurol. 2005;96:1-16. Review. No abstract available.
PMID: 16383208 [PubMed - indexed for MEDLINE]

46: Radad K, Gille G, Rausch WD.
Short review on dopamine agonists: insight into clinical and research studies
relevant to Parkinson's disease.
Pharmacol Rep. 2005 Nov-Dec;57(6):701-12. Review.
PMID: 16382188 [PubMed - indexed for MEDLINE]

47: Gogas KR.
Glutamate-based therapeutic approaches: NR2B receptor antagonists.
Curr Opin Pharmacol. 2006 Feb;6(1):68-74. Epub 2005 Dec 22. Review.
PMID: 16376149 [PubMed - indexed for MEDLINE]

48: Marin C, Rodriguez-Oroz MC, Obeso JA.
Motor complications in Parkinson's disease and the clinical significance of
rotational behavior in the rat: have we wasted our time?
Exp Neurol. 2006 Feb;197(2):269-74. Epub 2005 Dec 22. Review. No abstract
available.
PMID: 16375892 [PubMed - indexed for MEDLINE]

49: Maiese K, Chong ZZ, Li F.
Driving cellular plasticity and survival through the signal transduction pathways
of metabotropic glutamate receptors.
Curr Neurovasc Res. 2005 Dec;2(5):425-46. Review.
PMID: 16375723 [PubMed - indexed for MEDLINE]

50: da Costa CA.
Recent insights on the pro-apoptotic phenotype elicited by presenilin 2 and its
caspase and presenilinase-derived fragments.
Curr Alzheimer Res. 2005 Dec;2(5):507-14. Review.
PMID: 16375654 [PubMed - indexed for MEDLINE]

51: Dawson TM.
Failures and successes of clinical trials for Parkinson disease treatments.
Retina. 2005 Dec;25(8 Suppl):S75-S77. Review. No abstract available.
PMID: 16374349 [PubMed - indexed for MEDLINE]

52: Kawaja MD.
A proteomic approach to assess intraneuronal inclusions associated with
neurodegenerative disorders.
Curr Opin Mol Ther. 2005 Dec;7(6):565-8. Review.
PMID: 16370379 [PubMed - indexed for MEDLINE]

53: Chen JJ, Obering C.
A review of intermittent subcutaneous apomorphine injections for the rescue
management of motor fluctuations associated with advanced Parkinson's disease.
Clin Ther. 2005 Nov;27(11):1710-24. Review.
PMID: 16368444 [PubMed - indexed for MEDLINE]

54: Marino MJ, Conn PJ.
Glutamate-based therapeutic approaches: allosteric modulators of metabotropic
glutamate receptors.
Curr Opin Pharmacol. 2006 Feb;6(1):98-102. Epub 2005 Dec 20. Review.
PMID: 16368268 [PubMed - indexed for MEDLINE]

55: Kidd PM.
Neurodegeneration from mitochondrial insufficiency: nutrients, stem cells, growth
factors, and prospects for brain rebuilding using integrative management.
Altern Med Rev. 2005 Dec;10(4):268-93. Review.
PMID: 16366737 [PubMed - indexed for MEDLINE]

56: Ghorayeb I, Bezard E, Fernagut PO, Bioulac B, Tison F.
[Animal models of parkinsonism]
Rev Neurol (Paris). 2005 Oct;161(10):907-15. Review. French.
PMID: 16365620 [PubMed - indexed for MEDLINE]

57: Maltête D, Guyant-Maréchal L, Mihout B, Hannequin D.
Movement disorders and Creutzfeldt-Jakob disease: a review.
Parkinsonism Relat Disord. 2006 Mar;12(2):65-71. Epub 2005 Dec 20. Review.
PMID: 16364674 [PubMed - indexed for MEDLINE]

58: Murase N.
[Pathophysiology of dystonia]
No To Shinkei. 2005 Nov;57(11):957-72. Review. Japanese. No abstract available.
PMID: 16363635 [PubMed - indexed for MEDLINE]

59: Willis GL.
The role of ML-23 and other melatonin analogues in the treatment and management
of Parkinson's disease.
Drug News Perspect. 2005 Sep;18(7):437-44. Review.
PMID: 16362083 [PubMed - indexed for MEDLINE]

60: Cho HJ.
Reviving the old sermon of medicine with the placebo effect.
Rev Bras Psiquiatr. 2005 Dec;27(4):336-40. Epub 2005 Dec 12. Review.
PMID: 16358118 [PubMed - indexed for MEDLINE]

61: Nowak DA, Hermsdörfer J.
Objective evaluation of manual performance deficits in neurological movement
disorders.
Brain Res Rev. 2006 Jun;51(1):108-24. Epub 2005 Dec 13. Review.
PMID: 16356552 [PubMed - indexed for MEDLINE]

62: Konopka M, Członkowski A.
[Comparison of the safety of the medicinal product in the European Union and the
United States, tolcapone (Tasmar) -- COMT inhibitor as the analyzed example]
Neurol Neurochir Pol. 2005 Nov-Dec;39(6):490-6. Review. Polish.
PMID: 16355307 [PubMed - indexed for MEDLINE]

63: de Lange EC, Ravenstijn PG, Groenendaal D, van Steeg TJ.
Toward the prediction of CNS drug-effect profiles in physiological and
pathological conditions using microdialysis and mechanism-based
pharmacokinetic-pharmacodynamic modeling.
AAPS J. 2005 Oct 7;7(3):E532-43. Review.
PMID: 16353931 [PubMed - indexed for MEDLINE]

64: Bhidayasiri R.
Differential diagnosis of common tremor syndromes.
Postgrad Med J. 2005 Dec;81(962):756-62. Review.
PMID: 16344298 [PubMed - indexed for MEDLINE]

65: Zareba G.
Zonisamide: review of its use in epilepsy therapy.
Drugs Today (Barc). 2005 Sep;41(9):589-97. Review.
PMID: 16341290 [PubMed - indexed for MEDLINE]

66: Wada A, Yokoo H, Yanagita T, Kobayashi H.
Lithium: potential therapeutics against acute brain injuries and chronic
neurodegenerative diseases.
J Pharmacol Sci. 2005 Dec;99(4):307-21. Epub 2005 Dec 7. Review.
PMID: 16340157 [PubMed - indexed for MEDLINE]

67: Fillmore HL, Holloway KL, Gillies GT.
Cell replacement efforts to repair neuronal injury: a potential paradigm for the
treatment of Parkinson's disease.
NeuroRehabilitation. 2005;20(3):233-42. Review.
PMID: 16340103 [PubMed - indexed for MEDLINE]

68: Piper M, Abrams GM, Marks WJ Jr.
Deep brain stimulation for the treatment of Parkinson's disease: overview and
impact on gait and mobility.
NeuroRehabilitation. 2005;20(3):223-32. Review.
PMID: 16340102 [PubMed - indexed for MEDLINE]

69: Trail M, Fox C, Ramig LO, Sapir S, Howard J, Lai EC.
Speech treatment for Parkinson's disease.
NeuroRehabilitation. 2005;20(3):205-21. Review.
PMID: 16340101 [PubMed - indexed for MEDLINE]

70: Robinson K, Dennison A, Roalf D, Noorigian J, Cianci H, Bunting-Perry L,
Moberg P, Kleiner-Fisman G, Martine R, Duda J, Jaggi J, Stern M.
Falling risk factors in Parkinson's disease.
NeuroRehabilitation. 2005;20(3):169-82. Review.
PMID: 16340098 [PubMed - indexed for MEDLINE]

71: Leung H, Mok V.
Parkinson's disease: aetiology, diagnosis, and management.
Hong Kong Med J. 2005 Dec;11(6):476-89. Review.
PMID: 16340025 [PubMed - indexed for MEDLINE]

72: Morale MC, Serra PA, L'episcopo F, Tirolo C, Caniglia S, Testa N, Gennuso F,
Giaquinta G, Rocchitta G, Desole MS, Miele E, Marchetti B.
Estrogen, neuroinflammation and neuroprotection in Parkinson's disease: glia
dictates resistance versus vulnerability to neurodegeneration.
Neuroscience. 2006;138(3):869-78. Epub 2005 Dec 5. Review.
PMID: 16337092 [PubMed - indexed for MEDLINE]

73: Martin CJ.
Manganese neurotoxicity: connecting the dots along the continuum of dysfunction.
Neurotoxicology. 2006 May;27(3):347-9. Epub 2005 Dec 5. Review.
PMID: 16337002 [PubMed - indexed for MEDLINE]

74: Ferini-Strambi L, Fantini ML, Zucconi M, Castronovo V, Marelli S, Oldani A,
Cappa S.
REM sleep behaviour disorder.
Neurol Sci. 2005 Dec;26 Suppl 3:s186-92. Review.
PMID: 16331394 [PubMed - indexed for MEDLINE]

75: Chikina ES, Belousov IuB.
[Cost-effect pharmacological studies of Parkinson's disease]
Zh Nevrol Psikhiatr Im S S Korsakova. 2005;105(11):68-72. Review. Russian. No
abstract available.
PMID: 16329642 [PubMed - indexed for MEDLINE]

76: Cersosimo MG, Koller WC.
The diagnosis of manganese-induced parkinsonism.
Neurotoxicology. 2006 May;27(3):340-6. Epub 2005 Dec 1. Review.
PMID: 16325915 [PubMed - indexed for MEDLINE]

77: Eslamboli A.
Marmoset monkey models of Parkinson's disease: which model, when and why?
Brain Res Bull. 2005 Dec 30;68(3):140-9. Epub 2005 Sep 7. Review.
PMID: 16325013 [PubMed - indexed for MEDLINE]

78: Turnpenny L, Cameron IT, Spalluto CM, Hanley KP, Wilson DI, Hanley NA.
Human embryonic germ cells for future neuronal replacement therapy.
Brain Res Bull. 2005 Dec 15;68(1-2):76-82. Epub 2005 Sep 15. Review.
PMID: 16325007 [PubMed - indexed for MEDLINE]

79: Hagell P, Cenci MA.
Dyskinesias and dopamine cell replacement in Parkinson's disease: a clinical
perspective.
Brain Res Bull. 2005 Dec 15;68(1-2):4-15. Epub 2004 Dec 18. Review.
PMID: 16324999 [PubMed - indexed for MEDLINE]

80: García Vicente AM, Vaamonde Cano J, Soriano Castrejón A, Martínez Delgado C,
Talavera Rubio P, Poblete García VM, Ruiz Solís S, Rodado Marina S, Cortés Romera
M.
[Utility of 123-I ioflupane SPECT in the assessment of patients with Parkinsonian
syndrome and cerebral vasculopathy]
Rev Esp Med Nucl. 2005 Nov-Dec;24(6):392-403. Review. Spanish.
PMID: 16324516 [PubMed - indexed for MEDLINE]

81: Mínguez-Castellanos A, Escamilla-Sevilla F.
[Cell therapy and other neuroregenerative strategies in Parkinson's disease (II)]
Rev Neurol. 2005 Dec 1-15;41(11):684-93. Review. Spanish.
PMID: 16317638 [PubMed - indexed for MEDLINE]

82: Maguire-Zeiss KA, Federoff HJ.
Novel gene therapeutic strategies for neurodegenerative diseases.
Ernst Schering Res Found Workshop. 2005;(53):147-71. Review.
PMID: 16315613 [PubMed - indexed for MEDLINE]

83: Wang W, Wang DQ.
[Progress of study on brain protective effect and mechanism of Polygonum
multiflorum]
Zhongguo Zhong Xi Yi Jie He Za Zhi. 2005 Oct;25(10):955-9. Review. Chinese.
PMID: 16313126 [PubMed - indexed for MEDLINE]

84: Akaike A, Katsuki H, Kume T.
[Endogenous factors regulating neuronal apoptosis]
Nihon Shinkei Seishin Yakurigaku Zasshi. 2005 Oct;25(5):245-50. Review. Japanese.
PMID: 16313102 [PubMed - indexed for MEDLINE]

85: Van Craenenbroeck K, De Bosscher K, Vanden Berghe W, Vanhoenacker P, Haegeman
G.
Role of glucocorticoids in dopamine-related neuropsychiatric disorders.
Mol Cell Endocrinol. 2005 Dec 21;245(1-2):10-22. Epub 2005 Nov 28. Review.
PMID: 16310935 [PubMed - indexed for MEDLINE]

86: Schmidt O, Schulenborg T, Meyer HE, Marcus K, Hamacher M.
How proteomics reveals potential biomarkers in brain diseases.
Expert Rev Proteomics. 2005 Dec;2(6):901-13. Review.
PMID: 16307519 [PubMed - indexed for MEDLINE]

87: Henderson VW.
Menopause and disorders of the central nervous system.
Minerva Ginecol. 2005 Dec;57(6):579-92. Review.
PMID: 16306863 [PubMed - indexed for MEDLINE]

88: Dezawa M, Hoshino M, Nabeshima Y, Ide C.
Marrow stromal cells: implications in health and disease in the nervous system.
Curr Mol Med. 2005 Nov;5(7):723-32. Review.
PMID: 16305495 [PubMed - indexed for MEDLINE]

89: Chen LW, Yung KL, Chan YS.
Reactive astrocytes as potential manipulation targets in novel cell replacement
therapy of Parkinson's disease.
Curr Drug Targets. 2005 Nov;6(7):821-33. Review.
PMID: 16305461 [PubMed - indexed for MEDLINE]

90: Dzoljić E, Nesić Z, Stojanović R, Divac N, Todorović Z, Vucković S, Kostić V,
Prostran M.
[Nitric oxide, neurodegeneration, and Parkinson's disease]
Vojnosanit Pregl. 2005 Oct;62(10):751-6. Review. Serbian. No abstract available.
PMID: 16305103 [PubMed - indexed for MEDLINE]

91: Johnston TH, Fox SH, Brotchie JM.
Advances in the delivery of treatments for Parkinson's disease.
Expert Opin Drug Deliv. 2005 Nov;2(6):1059-73. Review.
PMID: 16296809 [PubMed - indexed for MEDLINE]

92: Grill WM.
Safety considerations for deep brain stimulation: review and analysis.
Expert Rev Med Devices. 2005 Jul;2(4):409-20. Review.
PMID: 16293080 [PubMed - indexed for MEDLINE]

93: Love S.
Neuropathological investigation of dementia: a guide for neurologists.
J Neurol Neurosurg Psychiatry. 2005 Dec;76 Suppl 5:v8-14. Review. No abstract
available.
PMID: 16291923 [PubMed - indexed for MEDLINE]

94: Fregni F, Simon DK, Wu A, Pascual-Leone A.
Non-invasive brain stimulation for Parkinson's disease: a systematic review and
meta-analysis of the literature.
J Neurol Neurosurg Psychiatry. 2005 Dec;76(12):1614-23. Review.
PMID: 16291882 [PubMed - indexed for MEDLINE]

95: Mínguez-Castellanos A, Escamilla-Sevilla F.
[Cell therapy and other neuroregenerative strategies in Parkinson's disease (I)]
Rev Neurol. 2005 Nov 16-30;41(10):604-14. Review. Spanish.
PMID: 16288424 [PubMed - indexed for MEDLINE]

96: Pham DQ, Plakogiannis R.
Vitamin E supplementation in Alzheimer's disease, Parkinson's disease, tardive
dyskinesia, and cataract: Part 2.
Ann Pharmacother. 2005 Dec;39(12):2065-72. Epub 2005 Nov 15. Review.
PMID: 16288072 [PubMed - indexed for MEDLINE]

97: Bilen J, Bonini NM.
Drosophila as a model for human neurodegenerative disease.
Annu Rev Genet. 2005;39:153-71. Review.
PMID: 16285856 [PubMed - indexed for MEDLINE]

98: Gilman S, May SJ, Shults CW, Tanner CM, Kukull W, Lee VM, Masliah E, Low P,
Sandroni P, Trojanowski JQ, Ozelius L, Foroud T; The North American Multiple
System Atrophy Study Group.
The North American Multiple System Atrophy Study Group.
J Neural Transm. 2005 Dec;112(12):1687-94. Review.
PMID: 16284910 [PubMed - indexed for MEDLINE]

99: Vodusek DB.
How to diagnose MSA early: the role of sphincter EMG.
J Neural Transm. 2005 Dec;112(12):1657-68. Review.
PMID: 16284909 [PubMed - indexed for MEDLINE]

100: Cilia R, Marotta G, Benti R, Pezzoli G, Antonini A.
Brain SPECT imaging in multiple system atrophy.
J Neural Transm. 2005 Dec;112(12):1635-45. Review.
PMID: 16284908 [PubMed - indexed for MEDLINE]

101: Vanacore N.
Epidemiological evidence on multiple system atrophy.
J Neural Transm. 2005 Dec;112(12):1605-12. Review.
PMID: 16284906 [PubMed - indexed for MEDLINE]

102: Reichmann H.
[Medication treatment for Parkinson's disease]
Nervenarzt. 2005 Dec;76(12):1547-57; quiz 1558. Review. German.
PMID: 16283151 [PubMed - indexed for MEDLINE]

103: Miller RM, Federoff HJ.
Altered gene expression profiles reveal similarities and differences between
Parkinson disease and model systems.
Neuroscientist. 2005 Dec;11(6):539-49. Review.
PMID: 16282595 [PubMed - indexed for MEDLINE]

104: von Steinbuechel N, Richter S, Morawetz C, Riemsma R.
Assessment of subjective health and health-related quality of life in persons
with acquired or degenerative brain injury.
Curr Opin Neurol. 2005 Dec;18(6):681-91. Review.
PMID: 16280680 [PubMed - indexed for MEDLINE]

105: Benabid AL, Chabardès S, Seigneuret E.
Deep-brain stimulation in Parkinson's disease: long-term efficacy and safety -
What happened this year?
Curr Opin Neurol. 2005 Dec;18(6):623-30. Review.
PMID: 16280671 [PubMed - indexed for MEDLINE]

106: Benedetti F, Mayberg HS, Wager TD, Stohler CS, Zubieta JK.
Neurobiological mechanisms of the placebo effect.
J Neurosci. 2005 Nov 9;25(45):10390-402. Review. No abstract available.
PMID: 16280578 [PubMed - indexed for MEDLINE]

107: Gandhi S, Wood NW.
Molecular pathogenesis of Parkinson's disease.
Hum Mol Genet. 2005 Oct 15;14 Spec No. 2:2749-2755. Review.
PMID: 16278972 [PubMed - indexed for MEDLINE]

108: Correia AS, Anisimov SV, Li JY, Brundin P.
Stem cell-based therapy for Parkinson's disease.
Ann Med. 2005;37(7):487-98. Review.
PMID: 16278162 [PubMed - indexed for MEDLINE]

109: Falk A, Frisén J.
New neurons in old brains.
Ann Med. 2005;37(7):480-6. Review.
PMID: 16278161 [PubMed - indexed for MEDLINE]

110: Conn PJ, Battaglia G, Marino MJ, Nicoletti F.
Metabotropic glutamate receptors in the basal ganglia motor circuit.
Nat Rev Neurosci. 2005 Oct;6(10):787-98. Review.
PMID: 16276355 [PubMed - indexed for MEDLINE]

111: Lerou PH, Daley GQ.
Therapeutic potential of embryonic stem cells.
Blood Rev. 2005 Nov;19(6):321-31. Review.
PMID: 16275420 [PubMed - indexed for MEDLINE]

112: Sparrow WA, Tirosh O.
Gait termination: a review of experimental methods and the effects of ageing and
gait pathologies.
Gait Posture. 2005 Dec;22(4):362-71. Epub 2005 Jan 7. Review.
PMID: 16274920 [PubMed - indexed for MEDLINE]

113: Merati AL, Heman-Ackah YD, Abaza M, Altman KW, Sulica L, Belamowicz S.
Common movement disorders affecting the larynx: a report from the
neurolaryngology committee of the AAO-HNS.
Otolaryngol Head Neck Surg. 2005 Nov;133(5):654-65. Review.
PMID: 16274788 [PubMed - indexed for MEDLINE]

114: Henchcliffe C, Schumacher HC, Burgut FT.
Recent advances in Parkinson's disease therapy: use of monoamine oxidase
inhibitors.
Expert Rev Neurother. 2005 Nov;5(6):811-21. Review.
PMID: 16274338 [PubMed - indexed for MEDLINE]

115: Lagopoulos J, Malhi GS, Ivanovski B, Cahill CM, Morris JG.
A matter of motion or an emotional matter? Management of depression in
Parkinson's disease.
Expert Rev Neurother. 2005 Nov;5(6):803-10. Review.
PMID: 16274337 [PubMed - indexed for MEDLINE]

116: Lew MF.
Selegiline orally disintegrating tablets for the treatment of Parkinson's
disease.
Expert Rev Neurother. 2005 Nov;5(6):705-12. Review.
PMID: 16274328 [PubMed - indexed for MEDLINE]

117: Derejko M, Niewiadomska M, Rakowicz M.
[The diagnostic and therapeutic application of transcranial magnetic stimulation]
Neurol Neurochir Pol. 2005 Sep-Oct;39(5):389-96. Review. Polish.
PMID: 16273463 [PubMed - indexed for MEDLINE]

118: Boczarska-Jedynak M, Opala G.
[Sleep disturbances in Parkinson's disease]
Neurol Neurochir Pol. 2005 Sep-Oct;39(5):380-8. Review. Polish.
PMID: 16273462 [PubMed - indexed for MEDLINE]

119: Jenkinson N, Nandi D, Aziz TZ, Stein JF.
Pedunculopontine nucleus: a new target for deep brain stimulation for akinesia.
Neuroreport. 2005 Nov 28;16(17):1875-6. Review. No abstract available.
PMID: 16272870 [PubMed - indexed for MEDLINE]

120: Alisauskiene M, Truffert A, Vaiciene N, Magistris MR.
Transcranial magnetic stimulation in clinical practice.
Medicina (Kaunas). 2005;41(10):813-24. Review.
PMID: 16272828 [PubMed - indexed for MEDLINE]

121: Reynolds NA, Wellington K, Easthope SE.
Rotigotine: in Parkinson's disease.
CNS Drugs. 2005;19(11):973-81. Review.
PMID: 16268667 [PubMed - indexed for MEDLINE]

122: Liimatainen S, Haapasalo H, Kähärä V, Paetau A, Honkaniemi J.
[Atypical Parkinsonian syndromes, a challenging group of diseases]
Duodecim. 2005;121(16):1757-66. Review. Finnish. No abstract available.
PMID: 16268222 [PubMed - indexed for MEDLINE]

123: Grotenhermen F.
Cannabinoids.
Curr Drug Targets CNS Neurol Disord. 2005 Oct;4(5):507-30. Review.
PMID: 16266285 [PubMed - indexed for MEDLINE]

124: Fowler JS, Logan J, Volkow ND, Wang GJ.
Translational neuroimaging: positron emission tomography studies of monoamine
oxidase.
Mol Imaging Biol. 2005 Nov-Dec;7(6):377-87. Review.
PMID: 16265597 [PubMed - indexed for MEDLINE]

125: Kadiu I, Glanzer JG, Kipnis J, Gendelman HE, Thomas MP.
Mononuclear phagocytes in the pathogenesis of neurodegenerative diseases.
Neurotox Res. 2005 Oct;8(1-2):25-50. Review.
PMID: 16260384 [PubMed - indexed for MEDLINE]

126: Houslay MD, Schafer P, Zhang KY.
Keynote review: phosphodiesterase-4 as a therapeutic target.
Drug Discov Today. 2005 Nov 15;10(22):1503-19. Review.
PMID: 16257373 [PubMed - indexed for MEDLINE]

127: Winogrodzka A, Booij J, Wolters ECh.
Disease-related and drug-induced changes in dopamine transporter expression might
undermine the reliability of imaging studies of disease progression in
Parkinson's disease.
Parkinsonism Relat Disord. 2005 Dec;11(8):475-84. Epub 2005 Oct 27. Review.
PMID: 16257254 [PubMed - indexed for MEDLINE]

128: Riaz SS, Bradford HF.
Factors involved in the determination of the neurotransmitter phenotype of
developing neurons of the CNS: applications in cell replacement treatment for
Parkinson's disease.
Prog Neurobiol. 2005 Jul;76(4):257-78. Epub 2005 Oct 26. Review.
PMID: 16256257 [PubMed - indexed for MEDLINE]

129: Scholtissen B, Verhey FR, Steinbusch HW, Leentjens AF.
Serotonergic mechanisms in Parkinson's disease: opposing results from preclinical
and clinical data.
J Neural Transm. 2006 Jan;113(1):59-73. Epub 2005 Oct 27. Review.
PMID: 16252066 [PubMed - indexed for MEDLINE]

130: Lim I, van Wegen E, de Goede C, Deutekom M, Nieuwboer A, Willems A, Jones D,
Rochester L, Kwakkel G.
Effects of external rhythmical cueing on gait in patients with Parkinson's
disease: a systematic review.
Clin Rehabil. 2005 Oct;19(7):695-713. Review.
PMID: 16250189 [PubMed - indexed for MEDLINE]

131: Adamis D, Sahu S, Treloar A.
The utility of EEG in dementia: a clinical perspective.
Int J Geriatr Psychiatry. 2005 Nov;20(11):1038-45. Review.
PMID: 16250070 [PubMed - indexed for MEDLINE]

132: Kosaka K.
[Progress of research on dementia with Lewy bodies]
Nippon Ronen Igakkai Zasshi. 2005 Sep;42(5):475-82. Review. Japanese. No abstract
available.
PMID: 16248403 [PubMed - indexed for MEDLINE]

133: Latchman DS.
Herpes simplex virus-based vectors for the treatment of cancer and
neurodegenerative disease.
Curr Opin Mol Ther. 2005 Oct;7(5):415-8. Review.
PMID: 16248276 [PubMed - indexed for MEDLINE]

134: Paleologou KE, Irvine GB, El-Agnaf OM.
Alpha-synuclein aggregation in neurodegenerative diseases and its inhibition as a
potential therapeutic strategy.
Biochem Soc Trans. 2005 Nov;33(Pt 5):1106-10. Review.
PMID: 16246056 [PubMed - indexed for MEDLINE]

135: Privat A.
[Stem cells and neural repair]
Bull Acad Natl Med. 2005 Apr;189(4):605-13; discussion 613-4. Review. French.
PMID: 16245679 [PubMed - indexed for MEDLINE]

136: Sayre LM, Moreira PI, Smith MA, Perry G.
Metal ions and oxidative protein modification in neurological disease.
Ann Ist Super Sanita. 2005;41(2):143-64. Review.
PMID: 16244388 [PubMed - indexed for MEDLINE]

137: Thorpy MJ, Adler CH.
Parkinson's disease and sleep.
Neurol Clin. 2005 Nov;23(4):1187-208. Review.
PMID: 16243622 [PubMed - indexed for MEDLINE]

138: Jankovic J, Chen S, Le WD.
The role of Nurr1 in the development of dopaminergic neurons and Parkinson's
disease.
Prog Neurobiol. 2005 Sep-Oct;77(1-2):128-38. Epub 2005 Oct 21. Review.
PMID: 16243425 [PubMed - indexed for MEDLINE]

139: Novakovic KE, Villemagne VL, Rowe CC, Masters CL.
Rare genetically defined causes of dementia.
Int Psychogeriatr. 2005;17 Suppl 1:S149-94. Review.
PMID: 16240489 [PubMed - indexed for MEDLINE]

140: Mravec B.
Salsolinol, a derivate of dopamine, is a possible modulator of catecholaminergic
transmission: a review of recent developments.
Physiol Res. 2006;55(4):353-64. Epub 2005 Oct 17. Review.
PMID: 16238467 [PubMed - indexed for MEDLINE]

141: Berto E, Bozac A, Marconi P.
Development and application of replication-incompetent HSV-1-based vectors.
Gene Ther. 2005 Oct;12 Suppl 1:S98-102. Review.
PMID: 16231061 [PubMed - indexed for MEDLINE]

142: Seibyl J, Jennings D, Tabamo R, Marek K.
The role of neuroimaging in the early diagnosis and evaluation of Parkinson's
disease.
Minerva Med. 2005 Oct;96(5):353-64. Review.
PMID: 16227950 [PubMed - indexed for MEDLINE]

143: Stepień K, Tomaszewski M, Czuczwar SJ.
Neuroprotective properties of statins.
Pharmacol Rep. 2005 Sep-Oct;57(5):561-9. Review.
PMID: 16227638 [PubMed - indexed for MEDLINE]

144: Schapira AH.
Present and future drug treatment for Parkinson's disease.
J Neurol Neurosurg Psychiatry. 2005 Nov;76(11):1472-8. Review.
PMID: 16227533 [PubMed - indexed for MEDLINE]

145: Lang AE, Miyasaki J, Olanow CW, Stoessl AJ, Suchowersky O.
Progress in clinical neurosciences: a forum on the early management of
Parkinson's disease.
Can J Neurol Sci. 2005 Aug;32(3):277-86. Review.
PMID: 16225167 [PubMed - indexed for MEDLINE]

146: Weintraub D, Stern MB.
Psychiatric complications in Parkinson disease.
Am J Geriatr Psychiatry. 2005 Oct;13(10):844-51. Review.
PMID: 16223962 [PubMed - indexed for MEDLINE]

147: Berney A, Vingerhoets F.
[Novel brain stimulation techniques: therapeutic perspectives in psychiatry]
Rev Med Suisse. 2005 Sep 21;1(33):2162-4, 2166. Review. French.
PMID: 16223219 [PubMed - indexed for MEDLINE]

148: Mizuno Y.
[In pursuit of the causes for Parkinson disease]
Nippon Naika Gakkai Zasshi. 2005 Sep 10;94(9):1761-73. Review. Japanese. No
abstract available.
PMID: 16223133 [PubMed - indexed for MEDLINE]

149: Stocchi F.
Optimising levodopa therapy for the management of Parkinson's disease.
J Neurol. 2005 Oct;252 Suppl 4:IV43-IV48. Review.
PMID: 16222437 [PubMed - indexed for MEDLINE]

150: Fahn S; and the Parkinson Study Group.
Does levodopa slow or hasten the rate of progression of Parkinson's disease?
J Neurol. 2005 Oct;252 Suppl 4:IV37-IV42. Review.
PMID: 16222436 [PubMed - indexed for MEDLINE]

151: Kondo T.
Levodopa therapy from the neuroprotection viewpoint. From a clinical outlook.
J Neurol. 2005 Oct;252 Suppl 4:IV32-IV36. Review.
PMID: 16222435 [PubMed - indexed for MEDLINE]

152: Ogawa N, Asanuma M, Miyazaki I, Diaz-Corrales FJ, Miyoshi K.
L-DOPA treatment from the viewpoint of neuroprotection. Possible mechanism of
specific and progressive dopaminergic neuronal death in Parkinson's disease.
J Neurol. 2005 Oct;252 Suppl 4:IV23-IV31. Review.
PMID: 16222434 [PubMed - indexed for MEDLINE]

153: Lindvall O, Kokaia Z.
Stem cell therapy for human brain disorders.
Kidney Int. 2005 Nov;68(5):1937-9. Review.
PMID: 16221169 [PubMed - indexed for MEDLINE]

154: Kato T.
[Mitochondrial dysfunction in bipolar disorder]
Nihon Shinkei Seishin Yakurigaku Zasshi. 2005 Apr;25(2):61-72. Review. Japanese.
PMID: 16220655 [PubMed - indexed for MEDLINE]

155: Li AA, Mink PJ, McIntosh LJ, Teta MJ, Finley B.
Evaluation of epidemiologic and animal data associating pesticides with
Parkinson's disease.
J Occup Environ Med. 2005 Oct;47(10):1059-87. Review.
PMID: 16217247 [PubMed - indexed for MEDLINE]

156: Mayo JC, Sainz RM, Tan DX, Antolín I, Rodríguez C, Reiter RJ.
Melatonin and Parkinson's disease.
Endocrine. 2005 Jul;27(2):169-78. Review.
PMID: 16217130 [PubMed - indexed for MEDLINE]

157: Fregni F, Pascual-Leone A.
Transcranial magnetic stimulation for the treatment of depression in neurologic
disorders.
Curr Psychiatry Rep. 2005 Oct;7(5):381-90. Review.
PMID: 16216159 [PubMed - indexed for MEDLINE]

158: Hol EM, van Leeuwen FW, Fischer DF.
The proteasome in Alzheimer's disease and Parkinson's disease: lessons from
ubiquitin B+1.
Trends Mol Med. 2005 Nov;11(11):488-95. Epub 2005 Oct 6. Review.
PMID: 16213790 [PubMed - indexed for MEDLINE]

159: Lim KL, Dawson VL, Dawson TM.
Parkin-mediated lysine 63-linked polyubiquitination: a link to protein inclusions
formation in Parkinson's and other conformational diseases?
Neurobiol Aging. 2006 Apr;27(4):524-9. Epub 2005 Oct 6. Review.
PMID: 16213628 [PubMed - indexed for MEDLINE]

160: Thanvi BR, Lo TC, Harsh DP.
Psychosis in Parkinson's disease.
Postgrad Med J. 2005 Oct;81(960):644-6. Review.
PMID: 16210460 [PubMed - indexed for MEDLINE]

161: Quik M, McIntosh JM.
Striatal alpha6* nicotinic acetylcholine receptors: potential targets for
Parkinson's disease therapy.
J Pharmacol Exp Ther. 2006 Feb;316(2):481-9. Epub 2005 Oct 6. Review.
PMID: 16210393 [PubMed - indexed for MEDLINE]

162: Levy R, Dubois B.
Apathy and the functional anatomy of the prefrontal cortex-basal ganglia
circuits.
Cereb Cortex. 2006 Jul;16(7):916-28. Epub 2005 Oct 5. Review.
PMID: 16207933 [PubMed - indexed for MEDLINE]

163: McNaught KS, Olanow CW.
Protein aggregation in the pathogenesis of familial and sporadic Parkinson's
disease.
Neurobiol Aging. 2006 Apr;27(4):530-45. Epub 2005 Oct 3. Review.
PMID: 16207501 [PubMed - indexed for MEDLINE]

164: Werner H.
The benefits of the dysphagia clinical nurse specialist role.
J Neurosci Nurs. 2005 Aug;37(4):212-5. Review.
PMID: 16206547 [PubMed - indexed for MEDLINE]

165: Gaeta A, Hider RC.
The crucial role of metal ions in neurodegeneration: the basis for a promising
therapeutic strategy.
Br J Pharmacol. 2005 Dec;146(8):1041-59. Review.
PMID: 16205720 [PubMed - indexed for MEDLINE]

166: McGeer EG, Klegeris A, McGeer PL.
Inflammation, the complement system and the diseases of aging.
Neurobiol Aging. 2005 Dec;26 Suppl 1:94-7. Epub 2005 Sep 29. Review.
PMID: 16198446 [PubMed - indexed for MEDLINE]

167: Rascol O.
Rasagiline in the pharmacotherapy of Parkinson's disease--a review.
Expert Opin Pharmacother. 2005 Oct;6(12):2061-75. Review.
PMID: 16197359 [PubMed - indexed for MEDLINE]

168: Fukuda H, Takahashi J.
Embryonic stem cells as a cell source for treating Parkinson's disease.
Expert Opin Biol Ther. 2005 Oct;5(10):1273-80. Review.
PMID: 16197334 [PubMed - indexed for MEDLINE]

169: Teunissen CE, van Boxtel MP, Jolles J, de Vente J, Vreeling F, Verhey F,
Polman CH, Dijkstra CD, Blom HJ.
Homocysteine in relation to cognitive performance in pathological and
non-pathological conditions.
Clin Chem Lab Med. 2005;43(10):1089-95. Review.
PMID: 16197303 [PubMed - indexed for MEDLINE]

170: Reutens S, Sachdev PS.
Periodic limb movements and other movement disorders in sleep: neuropsychiatric
dimensions.
Int Rev Psychiatry. 2005 Aug;17(4):283-92. Review.
PMID: 16194801 [PubMed - indexed for MEDLINE]

171: Lau FC, Shukitt-Hale B, Joseph JA.
The beneficial effects of fruit polyphenols on brain aging.
Neurobiol Aging. 2005 Dec;26 Suppl 1:128-32. Epub 2005 Sep 27. Review.
PMID: 16194581 [PubMed - indexed for MEDLINE]

172: Arushanian EB.
[Nootrope activity of ovarian estrogens]
Eksp Klin Farmakol. 2005 Jul-Aug;68(4):63-9. Review. Russian. No abstract
available.
PMID: 16193663 [PubMed - indexed for MEDLINE]

173: Romano G.
Current development of adeno-associated viral vectors.
Drug News Perspect. 2005 Jun;18(5):311-6. Review.
PMID: 16193103 [PubMed - indexed for MEDLINE]

174: Chung KK, Dawson TM, Dawson VL.
Nitric oxide, S-nitrosylation and neurodegeneration.
Cell Mol Biol (Noisy-le-grand). 2005 Sep 5;51(3):247-54. Review.
PMID: 16191392 [PubMed - indexed for MEDLINE]

175: Bonakdar RA, Guarneri E.
Coenzyme Q10.
Am Fam Physician. 2005 Sep 15;72(6):1065-70. Review.
PMID: 16190504 [PubMed - indexed for MEDLINE]

176: Knippschild U, Wolff S, Giamas G, Brockschmidt C, Wittau M, Würl PU, Eismann
T, Stöter M.
The role of the casein kinase 1 (CK1) family in different signaling pathways
linked to cancer development.
Onkologie. 2005 Oct;28(10):508-14. Epub 2005 Sep 19. Review.
PMID: 16186692 [PubMed - indexed for MEDLINE]

177: Lashuel HA.
Membrane permeabilization: a common mechanism in protein-misfolding diseases.
Sci Aging Knowledge Environ. 2005 Sep 21;2005(38):pe28. Review.
PMID: 16186179 [PubMed - indexed for MEDLINE]

178: Sullivan AM, O'Keeffe GW.
The role of growth/differentiation factor 5 (GDF5) in the induction and survival
of midbrain dopaminergic neurones: relevance to Parkinson's disease treatment.
J Anat. 2005 Sep;207(3):219-26. Review.
PMID: 16185246 [PubMed - indexed for MEDLINE]

179: Maxwell SL, Li M.
Midbrain dopaminergic development in vivo and in vitro from embryonic stem cells.
J Anat. 2005 Sep;207(3):209-18. Review.
PMID: 16185245 [PubMed - indexed for MEDLINE]

180: Gonzalez-Rey E, Chorny A, Fernandez-Martin A, Varela N, Delgado M.
Vasoactive intestinal peptide family as a therapeutic target for Parkinson's
disease.
Expert Opin Ther Targets. 2005 Oct;9(5):923-9. Review.
PMID: 16185148 [PubMed - indexed for MEDLINE]

181: Mariani E, Polidori MC, Cherubini A, Mecocci P.
Oxidative stress in brain aging, neurodegenerative and vascular diseases: an
overview.
J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Nov 15;827(1):65-75. Epub
2005 Sep 23. Review.
PMID: 16183338 [PubMed - indexed for MEDLINE]

182: Williams A, Ramsden D.
Nicotinamide: a double edged sword.
Parkinsonism Relat Disord. 2005 Nov;11(7):413-20. Epub 2005 Sep 23. Review.
PMID: 16183323 [PubMed - indexed for MEDLINE]

183: Németh H, Toldi J, Vécsei L.
Role of kynurenines in the central and peripheral nervous systems.
Curr Neurovasc Res. 2005 Jul;2(3):249-60. Review.
PMID: 16181118 [PubMed - indexed for MEDLINE]

184: Veazey C, Aki SO, Cook KF, Lai EC, Kunik ME.
Prevalence and treatment of depression in Parkinson's disease.
J Neuropsychiatry Clin Neurosci. 2005 Summer;17(3):310-23. Review.
PMID: 16179652 [PubMed - indexed for MEDLINE]

185: Mandel S, Grunblatt E, Riederer P, Amariglio N, Jacob-Hirsch J, Rechavi G,
Youdim MB.
Gene expression profiling of sporadic Parkinson's disease substantia nigra pars
compacta reveals impairment of ubiquitin-proteasome subunits, SKP1A, aldehyde
dehydrogenase, and chaperone HSC-70.
Ann N Y Acad Sci. 2005 Aug;1053:356-75. Review.
PMID: 16179542 [PubMed - indexed for MEDLINE]

186: Srinivasan V, Pandi-Perumal SR, Maestroni GJ, Esquifino AI, Hardeland R,
Cardinali DP.
Role of melatonin in neurodegenerative diseases.
Neurotox Res. 2005;7(4):293-318. Review.
PMID: 16179266 [PubMed - indexed for MEDLINE]

187: Marino MJ, Hess JF, Liverton N.
Targeting the metabotropic glutamate receptor mGluR4 for the treatment of
diseases of the central nervous system.
Curr Top Med Chem. 2005;5(9):885-95. Review.
PMID: 16178733 [PubMed - indexed for MEDLINE]

188: Niswender CM, Jones CK, Conn PJ.
New therapeutic frontiers for metabotropic glutamate receptors.
Curr Top Med Chem. 2005;5(9):847-57. Review.
PMID: 16178730 [PubMed - indexed for MEDLINE]

189: Beal MF.
Mitochondria take center stage in aging and neurodegeneration.
Ann Neurol. 2005 Oct;58(4):495-505. Review.
PMID: 16178023 [PubMed - indexed for MEDLINE]

190: Yang SY, He XY, Schulz H.
3-Hydroxyacyl-CoA dehydrogenase and short chain 3-hydroxyacyl-CoA dehydrogenase
in human health and disease.
FEBS J. 2005 Oct;272(19):4874-83. Review.
PMID: 16176262 [PubMed - indexed for MEDLINE]

191: Bonifati V.
Genetics of Parkinson's disease.
Minerva Med. 2005 Jun;96(3):175-86. Review.
PMID: 16175160 [PubMed - indexed for MEDLINE]

192: Lauterbach EC.
The neuropsychiatry of Parkinson's disease.
Minerva Med. 2005 Jun;96(3):155-73. Review.
PMID: 16175159 [PubMed - indexed for MEDLINE]

193: Bhat V, Weiner WJ.
Parkinson's disease. Diagnosis and the initiation of therapy.
Minerva Med. 2005 Jun;96(3):145-54. Review.
PMID: 16175158 [PubMed - indexed for MEDLINE]

194: Buracchio T, Arvanitakis Z, Gorbien M.
Dementia with Lewy bodies: current concepts.
Dement Geriatr Cogn Disord. 2005;20(5):306-20. Epub 2005 Sep 19. Review.
PMID: 16174977 [PubMed - indexed for MEDLINE]

195: Pal PK, Netravathi M.
Management of neurodegenerative disorders: Parkinson's disease and Alzheimer's
disease.
J Indian Med Assoc. 2005 Mar;103(3):168-70, 172, 174-6. Review.
PMID: 16173294 [PubMed - indexed for MEDLINE]

196: Ghosh B, Mishra A, Sengupta P.
Is Parkinson's disease a homogeneous disorder--what is the burden of Parkinson's
disease in India.
J Indian Med Assoc. 2005 Mar;103(3):146, 148, 150 passim. Review.
PMID: 16173291 [PubMed - indexed for MEDLINE]

197: Jain S, Wood NW, Healy DG.
Molecular genetic pathways in Parkinson's disease: a review.
Clin Sci (Lond). 2005 Oct;109(4):355-64. Review.
PMID: 16171459 [PubMed - indexed for MEDLINE]

198: Hoerndli F, David DC, Götz J.
Functional Genomics meets neurodegenerative disorders. Part II: application and
data integration.
Prog Neurobiol. 2005 Jun;76(3):169-88. Review.
PMID: 16169146 [PubMed - indexed for MEDLINE]

199: Möller JC, Oertel WH.
Pramipexole in the treatment of Parkinson's disease: new developments.
Expert Rev Neurother. 2005 Sep;5(5):581-6. Review.
PMID: 16162081 [PubMed - indexed for MEDLINE]

200: Desai AK, Grossberg GT.
Rivastigmine for Alzheimer's disease.
Expert Rev Neurother. 2005 Sep;5(5):563-80. Review.
PMID: 16162080 [PubMed - indexed for MEDLINE]

201: Lees A.
Alternatives to levodopa in the initial treatment of early Parkinson's disease.
Drugs Aging. 2005;22(9):731-40. Review.
PMID: 16156677 [PubMed - indexed for MEDLINE]

202: Wyllie MG.
The underlying pathophysiology and causes of erectile dysfunction.
Clin Cornerstone. 2005;7(1):19-27. Review.
PMID: 16156420 [PubMed - indexed for MEDLINE]

203: Howell N, Elson JL, Chinnery PF, Turnbull DM.
mtDNA mutations and common neurodegenerative disorders.
Trends Genet. 2005 Nov;21(11):583-6. Epub 2005 Sep 8. Review.
PMID: 16154228 [PubMed - indexed for MEDLINE]

204: Poryazova RG, Zachariev ZI.
REM sleep behavior disorder in patients with Parkinson's disease.
Folia Med (Plovdiv). 2005;47(1):5-10. Review.
PMID: 16152765 [PubMed - indexed for MEDLINE]

205: Ozono R.
[Dopamine]
Nippon Rinsho. 2005 Aug;63 Suppl 8:388-90. Review. Japanese. No abstract
available.
PMID: 16149536 [PubMed - indexed for MEDLINE]

206: Sasaki M, Sanada H.
[3,4-Dihydroxyphenylacetic acid (DOPAC)]
Nippon Rinsho. 2005 Aug;63 Suppl 8:384-7. Review. Japanese. No abstract
available.
PMID: 16149535 [PubMed - indexed for MEDLINE]

207: Yatabe J, Sanada H.
[3,4-Dihydroxyphenyl alanine (DOPA)]
Nippon Rinsho. 2005 Aug;63 Suppl 8:380-3. Review. Japanese. No abstract
available.
PMID: 16149534 [PubMed - indexed for MEDLINE]

208: Nutt JG, Wooten GF.
Clinical practice. Diagnosis and initial management of Parkinson's disease.
N Engl J Med. 2005 Sep 8;353(10):1021-7. Review. No abstract available.
PMID: 16148287 [PubMed - indexed for MEDLINE]

209: Ishimaru T.
[Recent clinical trends in smell disorder]
No To Shinkei. 2005 Aug;57(8):659-66. Review. Japanese. No abstract available.
PMID: 16146210 [PubMed - indexed for MEDLINE]

210: Smigrodzki RM, Khan SM.
Mitochondrial microheteroplasmy and a theory of aging and age-related disease.
Rejuvenation Res. 2005 Fall;8(3):172-98. Review.
PMID: 16144471 [PubMed - indexed for MEDLINE]

211: Taylor H, Minger SL.
Regenerative medicine in Parkinson's disease: generation of mesencephalic
dopaminergic cells from embryonic stem cells.
Curr Opin Biotechnol. 2005 Oct;16(5):487-92. Review.
PMID: 16143504 [PubMed - indexed for MEDLINE]

212: Scherder E, Wolters E, Polman C, Sergeant J, Swaab D.
Pain in Parkinson's disease and multiple sclerosis: its relation to the medial
and lateral pain systems.
Neurosci Biobehav Rev. 2005;29(7):1047-56. Review.
PMID: 16143170 [PubMed - indexed for MEDLINE]

213: Wu SS, Frucht SJ.
Treatment of Parkinson's disease : what's on the horizon?
CNS Drugs. 2005;19(9):723-43. Review.
PMID: 16142989 [PubMed - indexed for MEDLINE]

214: Corvol JC, Schüpbach M, Bonnet AM; Centre d'Investigation Clinique et
Fédération des Maladies du Système Nerveux, Hôpital de la Pitié-Salpêtrière,
Paris.
[Pergolide associated valvulopathy: critical analysis of the literature and
practical recommendations]
Rev Neurol (Paris). 2005 Jul;161(6-7):637-43. Review. French.
PMID: 16141947 [PubMed - indexed for MEDLINE]

215: Nakajima M, Yokoi T.
Interindividual variability in nicotine metabolism: C-oxidation and
glucuronidation.
Drug Metab Pharmacokinet. 2005 Aug;20(4):227-35. Review.
PMID: 16141602 [PubMed - indexed for MEDLINE]

216: Logroscino G.
The role of early life environmental risk factors in Parkinson disease: what is
the evidence?
Environ Health Perspect. 2005 Sep;113(9):1234-8. Review.
PMID: 16140634 [PubMed - indexed for MEDLINE]

217: Landrigan PJ, Sonawane B, Butler RN, Trasande L, Callan R, Droller D.
Early environmental origins of neurodegenerative disease in later life.
Environ Health Perspect. 2005 Sep;113(9):1230-3. Review.
PMID: 16140633 [PubMed - indexed for MEDLINE]

218: Paschen W, Mengesdorf T.
Cellular abnormalities linked to endoplasmic reticulum dysfunction in
cerebrovascular disease--therapeutic potential.
Pharmacol Ther. 2005 Dec;108(3):362-75. Epub 2005 Sep 2. Review.
PMID: 16140387 [PubMed - indexed for MEDLINE]

219: Clarke C, Moore AP.
Parkinson's disease.
Clin Evid. 2005 Jun;(13):1658-77. Review. No abstract available.
PMID: 16135305 [PubMed - indexed for MEDLINE]

220: Lewthwaite AJ, Nicholl DJ.
Genetics of parkinsonism.
Curr Neurol Neurosci Rep. 2005 Sep;5(5):397-404. Review.
PMID: 16131423 [PubMed - indexed for MEDLINE]

221: Stout JC, Johnson SA.
Cognitive impairment and dementia in basal ganglia disorders.
Curr Neurol Neurosci Rep. 2005 Sep;5(5):355-63. Review.
PMID: 16131418 [PubMed - indexed for MEDLINE]

222: Burn DJ.
Update on dementia with Lewy bodies.
Curr Neurol Neurosci Rep. 2005 Sep;5(5):339-44. Review.
PMID: 16131416 [PubMed - indexed for MEDLINE]

223: Gandhi S, Wood NW.
Molecular pathogenesis of Parkinson's disease.
Hum Mol Genet. 2005 Sep 15;14(18):2749-55. Epub 2005 Aug 26. Review. Corrected
and republished in: Hum Mol Genet. 2005 Oct 15;14 Spec No. 2:2749-2755.
PMID: 16126732 [PubMed - indexed for MEDLINE]

224: Marchetti B, Abbracchio MP.
To be or not to be (inflamed)--is that the question in anti-inflammatory drug
therapy of neurodegenerative disorders?
Trends Pharmacol Sci. 2005 Oct;26(10):517-25. Review.
PMID: 16126283 [PubMed - indexed for MEDLINE]

225: Levenson CW.
Trace metal regulation of neuronal apoptosis: from genes to behavior.
Physiol Behav. 2005 Oct 15;86(3):399-406. Epub 2005 Aug 24. Review.
PMID: 16125208 [PubMed - indexed for MEDLINE]

226: Sukhanov VA, Ionov ID, Piruzian LA.
[Neurodegenerative disorders: the role of genetic factors in their origin and the
efficiency of treatment]
Fiziol Cheloveka. 2005 Jul-Aug;31(4):119-30. Review. Russian. No abstract
available.
PMID: 16122046 [PubMed - indexed for MEDLINE]

227: McCrery RJ, Appell RA.
Female neurogenic vesicourethral dysfunction: evaluation and management.
Curr Urol Rep. 2005 Sep;6(5):348-55. Review.
PMID: 16120235 [PubMed - indexed for MEDLINE]

228: Ludin HP.
[Idiopathic Parkinson's disease: practical hints for the treatment]
Schweiz Rundsch Med Prax. 2005 Jul 27;94(30-31):1147-50. Review. German.
PMID: 16117469 [PubMed - indexed for MEDLINE]

229: Mazo EB, Krivoborodov GG.
[Neurological aspect of the hyperactive urinary bladder syndrome]
Zh Nevrol Psikhiatr Im S S Korsakova. 2005;105(7):58-62. Review. Russian. No
abstract available.
PMID: 16117151 [PubMed - indexed for MEDLINE]

230: Guix FX, Uribesalgo I, Coma M, Muñoz FJ.
The physiology and pathophysiology of nitric oxide in the brain.
Prog Neurobiol. 2005 Jun;76(2):126-52. Review.
PMID: 16115721 [PubMed - indexed for MEDLINE]

231: Adam-Vizi V.
Production of reactive oxygen species in brain mitochondria: contribution by
electron transport chain and non-electron transport chain sources.
Antioxid Redox Signal. 2005 Sep-Oct;7(9-10):1140-9. Review.
PMID: 16115017 [PubMed - indexed for MEDLINE]

232: Kanthasamy AG, Kitazawa M, Kanthasamy A, Anantharam V.
Dieldrin-induced neurotoxicity: relevance to Parkinson's disease pathogenesis.
Neurotoxicology. 2005 Aug;26(4):701-19. Review.
PMID: 16112328 [PubMed - indexed for MEDLINE]

233: Fernandez-Espejo E, Armengol JA, Flores JA, Galan-Rodriguez B, Ramiro S.
Cells of the sympathoadrenal lineage: biological properties as donor tissue for
cell-replacement therapies for Parkinson's disease.
Brain Res Brain Res Rev. 2005 Sep;49(2):343-54. Epub 2005 Mar 2. Review.
PMID: 16111561 [PubMed - indexed for MEDLINE]

234: Youdim MB, Maruyama W, Naoi M.
Neuropharmacological, neuroprotective and amyloid precursor processing properties
of selective MAO-B inhibitor antiparkinsonian drug, rasagiline.
Drugs Today (Barc). 2005 Jun;41(6):369-91. Review.
PMID: 16110345 [PubMed - indexed for MEDLINE]

235: Diamond A, Jankovic J.
The effect of deep brain stimulation on quality of life in movement disorders.
J Neurol Neurosurg Psychiatry. 2005 Sep;76(9):1188-93. Review.
PMID: 16107348 [PubMed - indexed for MEDLINE]

236: Drozak J, Bryła J.
[Dopamine: not just a neurotransmitter]
Postepy Hig Med Dosw (Online). 2005;59:405-20. Review. Polish.
PMID: 16106242 [PubMed - indexed for MEDLINE]

237: Findlay VJ, Tapiero H, Townsend DM.
Sulfiredoxin: a potential therapeutic agent?
Biomed Pharmacother. 2005 Aug;59(7):374-9. Review.
PMID: 16102934 [PubMed - indexed for MEDLINE]

238: Franke H, Illes P.
Involvement of P2 receptors in the growth and survival of neurons in the CNS.
Pharmacol Ther. 2006 Mar;109(3):297-324. Epub 2005 Aug 15. Review.
PMID: 16102837 [PubMed - indexed for MEDLINE]

239: Forman MS, Lee VM, Trojanowski JQ.
Nosology of Parkinson's disease: looking for the way out of a quagmire.
Neuron. 2005 Aug 18;47(4):479-82. Review.
PMID: 16102530 [PubMed - indexed for MEDLINE]

240: Cardoso SM, Moreira PI, Agostinho P, Pereira C, Oliveira CR.
Neurodegenerative pathways in Parkinson's disease: therapeutic strategies.
Curr Drug Targets CNS Neurol Disord. 2005 Aug;4(4):405-19. Review.
PMID: 16101557 [PubMed - indexed for MEDLINE]

241: Tzeng SF, Hsiao HY, Mak OT.
Prostaglandins and cyclooxygenases in glial cells during brain inflammation.
Curr Drug Targets Inflamm Allergy. 2005 Jun;4(3):335-40. Review.
PMID: 16101543 [PubMed - indexed for MEDLINE]

242: von Bohlen und Halbach O.
The renin-angiotensin system in the mammalian central nervous system.
Curr Protein Pept Sci. 2005 Aug;6(4):355-71. Review.
PMID: 16101434 [PubMed - indexed for MEDLINE]

243: Dickerson LM, Young SE, Simpson WM, Nashelsky J.
Treatment of early Parkinson's disease.
Am Fam Physician. 2005 Aug 1;72(3):497-500. Review. No abstract available.
PMID: 16100865 [PubMed - indexed for MEDLINE]

244: Aschner JL, Aschner M.
Nutritional aspects of manganese homeostasis.
Mol Aspects Med. 2005 Aug-Oct;26(4-5):353-62. Review.
PMID: 16099026 [PubMed - indexed for MEDLINE]

245: Muller JE, Koen L, Stein DJ.
Anxiety and medical disorders.
Curr Psychiatry Rep. 2005 Aug;7(4):245-51. Review.
PMID: 16098277 [PubMed - indexed for MEDLINE]

246: Jean-Luc H.
[Parkinson's disease]
Rev Prat. 2005 May 31;55(10):1129-34. Review. French. No abstract available.
PMID: 16097259 [PubMed - indexed for MEDLINE]

247: Heikkilä VM, Kallanranta T.
Evaluation of the driving ability in disabled persons: a practitioners' view.
Disabil Rehabil. 2005 Sep 2;27(17):1029-36. Review.
PMID: 16096257 [PubMed - indexed for MEDLINE]

248: Gandhi S, Abou-Sleiman PM, Healy DG, Weale M, Gilks W, Ahmadi K, Goldstein
DB, Wood NW.
Population genetic approaches to neurological disease: Parkinson's disease as an
example.
Philos Trans R Soc Lond B Biol Sci. 2005 Aug 29;360(1460):1573-8. Review.
PMID: 16096106 [PubMed - indexed for MEDLINE]

249: Kuan WL, Barker RA.
New therapeutic approaches to Parkinson's disease including neural transplants.
Neurorehabil Neural Repair. 2005 Sep;19(3):155-81. Review.
PMID: 16093408 [PubMed - indexed for MEDLINE]

250: Grosset KA, Reid JL, Grosset DG.
Medicine-taking behavior: implications of suboptimal compliance in Parkinson's
disease.
Mov Disord. 2005 Nov;20(11):1397-404. Review.
PMID: 16092116 [PubMed - indexed for MEDLINE]

251: Geser F, Wenning GK, Poewe W, McKeith I.
How to diagnose dementia with Lewy bodies: state of the art.
Mov Disord. 2005 Aug;20 Suppl 12:S11-20. Review.
PMID: 16092075 [PubMed - indexed for MEDLINE]

252: Rothenhäusler HB, Kapfhammer HP.
[Psychopharmacotherapy in somatic diseases -- treatment principles in daily
medical routine]
Wien Med Wochenschr. 2005 Jul;155(13-14):303-14. Review. German.
PMID: 16092037 [PubMed - indexed for MEDLINE]

253: Potulska A, Friedman A.
Controlling sialorrhoea: a review of available treatment options.
Expert Opin Pharmacother. 2005 Aug;6(9):1551-4. Review.
PMID: 16086642 [PubMed - indexed for MEDLINE]

254: Eibenstein A, Fioretti AB, Lena C, Rosati N, Amabile G, Fusetti M.
Modern psychophysical tests to assess olfactory function.
Neurol Sci. 2005 Jul;26(3):147-55. Review.
PMID: 16086127 [PubMed - indexed for MEDLINE]

255: Gilman S.
Functional imaging with positron emission tomography in multiple system atrophy.
J Neural Transm. 2005 Dec;112(12):1647-55. Epub 2005 Aug 5. Review.
PMID: 16082507 [PubMed - indexed for MEDLINE]

256: Olakowska E, Marcol W, Kotulska K, Lewin-Kowalik J.
The role of melatonin in the neurodegenerative diseases.
Bratisl Lek Listy. 2005;106(4-5):171-4. Review.
PMID: 16080363 [PubMed - indexed for MEDLINE]

257: Abe K, Saitoh T, Horiguchi Y, Utsunomiya I, Taguchi K.
Synthesis and neurotoxicity of tetrahydroisoquinoline derivatives for studying
Parkinson's disease.
Biol Pharm Bull. 2005 Aug;28(8):1355-62. Review.
PMID: 16079473 [PubMed - indexed for MEDLINE]

258: Johnson MD, Yu LR, Conrads TP, Kinoshita Y, Uo T, McBee JK, Veenstra TD,
Morrison RS.
The proteomics of neurodegeneration.
Am J Pharmacogenomics. 2005;5(4):259-70. Review.
PMID: 16078862 [PubMed - indexed for MEDLINE]

259: Bonci A, Hopf FW.
The dopamine D2 receptor: new surprises from an old friend.
Neuron. 2005 Aug 4;47(3):335-8. Review.
PMID: 16055058 [PubMed - indexed for MEDLINE]

260: Schnitzler A, Timmermann L, Gross J.
Physiological and pathological oscillatory networks in the human motor system.
J Physiol Paris. 2006 Jan;99(1):3-7. Epub 2005 Jul 27. Review.
PMID: 16054347 [PubMed - indexed for MEDLINE]

261: Liu J, Ames BN.
Reducing mitochondrial decay with mitochondrial nutrients to delay and treat
cognitive dysfunction, Alzheimer's disease, and Parkinson's disease.
Nutr Neurosci. 2005 Apr;8(2):67-89. Review.
PMID: 16053240 [PubMed - indexed for MEDLINE]

262: Conti AA, Conti A, Masoni M, Gensini GF.
Clinical pictures of unknown origin in neurology: past, present and future
usefulness of artificial intelligence.
Ann Ital Med Int. 2005 Apr-Jun;20(2):113-6. Review.
PMID: 16052845 [PubMed - indexed for MEDLINE]

263: Björklund A.
Cell therapy for Parkinson's disease: problems and prospects.
Novartis Found Symp. 2005;265:174-86; discussion 187, 204-211. Review.
PMID: 16050257 [PubMed - indexed for MEDLINE]

264: Geser F, Seppi K, Stampfer-Kountchev M, Köllensperger M, Diem A, Ndayisaba
JP, Ostergaard K, Dupont E, Cardozo A, Tolosa E, Abele M, Dodel R, Klockgether T,
Ghorayeb I, Yekhlef F, Tison F, Daniels C, Kopper F, Deuschl G, Coelho M,
Ferreira J, Rosa MM, Sampaio C, Bozi M, Schrag A, Hooker J, Kim H, Scaravilli T,
Mathias CJ, Fowler C, Wood N, Quinn N, Widner H, Nilsson CF, Lindvall O, Schimke
N, Eggert KM, Oertel W, del Sorbo F, Carella F, Albanese A, Pellecchia MT, Barone
P, Djaldetti R, Meco G, Colosimo C, Gonzalez-Mandly A, Berciano J, Gurevich T,
Giladi N, Galitzky M, Ory F, Rascol O, Kamm C, Buerk K, Maass S, Gasser T, Poewe
W, Wenning GK; EMSA-SG.
The European Multiple System Atrophy-Study Group (EMSA-SG).
J Neural Transm. 2005 Dec;112(12):1677-86. Epub 2005 Jul 29. Review.
PMID: 16049636 [PubMed - indexed for MEDLINE]

265: Meriin AB, Sherman MY.
Role of molecular chaperones in neurodegenerative disorders.
Int J Hyperthermia. 2005 Aug;21(5):403-19. Review.
PMID: 16048838 [PubMed - indexed for MEDLINE]

266: Del Bel EA, Guimarães FS, Bermúdez-Echeverry M, Gomes MZ, Schiaveto-de-souza
A, Padovan-Neto FE, Tumas V, Barion-Cavalcanti AP, Lazzarini M, Nucci-da-Silva
LP, de Paula-Souza D.
Role of nitric oxide on motor behavior.
Cell Mol Neurobiol. 2005 Mar;25(2):371-92. Review.
PMID: 16047547 [PubMed - indexed for MEDLINE]

267: Grosset D, Grosset K.
Spheramine Titan/Schering.
Curr Opin Investig Drugs. 2005 Jul;6(7):722-8. Review.
PMID: 16044669 [PubMed - indexed for MEDLINE]

268: Alexander NB, Goldberg A.
Gait disorders: search for multiple causes.
Cleve Clin J Med. 2005 Jul;72(7):586, 589-90, 592-4 passim. Review.
PMID: 16044655 [PubMed - indexed for MEDLINE]

269: Ross OA, Farrer MJ.
Pathophysiology, pleiotrophy and paradigm shifts: genetic lessons from
Parkinson's disease.
Biochem Soc Trans. 2005 Aug;33(Pt 4):586-90. Review.
PMID: 16042550 [PubMed - indexed for MEDLINE]

270: Hardy J.
Expression of normal sequence pathogenic proteins for neurodegenerative disease
contributes to disease risk: 'permissive templating' as a general mechanism
underlying neurodegeneration.
Biochem Soc Trans. 2005 Aug;33(Pt 4):578-81. Review.
PMID: 16042548 [PubMed - indexed for MEDLINE]

271: Aarsland D, Zaccai J, Brayne C.
A systematic review of prevalence studies of dementia in Parkinson's disease.
Mov Disord. 2005 Oct;20(10):1255-63. Review.
PMID: 16041803 [PubMed - indexed for MEDLINE]

272: Siniscalchi A, Mancuso F, Gallelli L, Ferreri Ibbadu G, Biagio Mercuri N, De
Sarro G.
Increase in plasma homocysteine levels induced by drug treatments in neurologic
patients.
Pharmacol Res. 2005 Nov;52(5):367-75. Epub 2005 Jul 20. Review.
PMID: 16039138 [PubMed - indexed for MEDLINE]

273: Lennecke K.
[Pharmaceutical care of Parkinson patients]
Med Monatsschr Pharm. 2005 Jul;28(7):228-36; quiz 237-8. Review. German. No
abstract available.
PMID: 16038120 [PubMed - indexed for MEDLINE]

274: Macleod AD, Counsell CE, Ives N, Stowe R.
Monoamine oxidase B inhibitors for early Parkinson's disease.
Cochrane Database Syst Rev. 2005 Jul 20;(3):CD004898. Review.
PMID: 16034956 [PubMed - indexed for MEDLINE]

275: Frank S, Kieburtz K, Holloway R, Kim SY.
What is the risk of sham surgery in Parkinson disease clinical trials? A review
of published reports.
Neurology. 2005 Oct 11;65(7):1101-3. Epub 2005 Jul 20. Review.
PMID: 16033990 [PubMed - indexed for MEDLINE]

276: Pfeiffer RF.
A promising new technology for Parkinson's disease.
Neurology. 2005 Jul 26;65(2 Suppl 1):S6-10. Review. No abstract available.
PMID: 16030292 [PubMed - indexed for MEDLINE]

277: Jenner P.
A novel dopamine agonist for the transdermal treatment of Parkinson's disease.
Neurology. 2005 Jul 26;65(2 Suppl 1):S3-5. Review.
PMID: 16030291 [PubMed - indexed for MEDLINE]

278: Poewe W, Luessi F.
Clinical studies with transdermal rotigotine in early Parkinson's disease.
Neurology. 2005 Jul 26;65(2 Suppl 1):S11-4. Review. No abstract available.
Erratum in: Neurology. 2005 Oct 25;65(8):1328.
PMID: 16030290 [PubMed - indexed for MEDLINE]

279: Brown P, Williams D.
Basal ganglia local field potential activity: character and functional
significance in the human.
Clin Neurophysiol. 2005 Nov;116(11):2510-9. Epub 2005 Jul 18. Review.
PMID: 16029963 [PubMed - indexed for MEDLINE]

280: Krishnan KR.
Treatment of depression in the medically ill.
J Clin Psychopharmacol. 2005 Aug;25(4 Suppl 1):S14-8. Review.
PMID: 16027555 [PubMed - indexed for MEDLINE]

281: Chen JJ, Swope DM.
Clinical pharmacology of rasagiline: a novel, second-generation propargylamine
for the treatment of Parkinson disease.
J Clin Pharmacol. 2005 Aug;45(8):878-94. Review.
PMID: 16027398 [PubMed - indexed for MEDLINE]

282: Vajda FJ, Solinas C.
Current approaches to management of depression in Parkinson's Disease.
J Clin Neurosci. 2005 Sep;12(7):739-43. Review.
PMID: 16026985 [PubMed - indexed for MEDLINE]

283: Deogaonkar M, Subramanian T.
Pathophysiological basis of drug-induced dyskinesias in Parkinson's disease.
Brain Res Brain Res Rev. 2005 Dec 1;50(1):156-68. Epub 2005 Jul 18. Review.
PMID: 16026845 [PubMed - indexed for MEDLINE]

284: Virág L.
Structure and function of poly(ADP-ribose) polymerase-1: role in oxidative
stress-related pathologies.
Curr Vasc Pharmacol. 2005 Jul;3(3):209-14. Review.
PMID: 16026317 [PubMed - indexed for MEDLINE]

285: Morris HR.
Genetics of Parkinson's disease.
Ann Med. 2005;37(2):86-96. Review.
PMID: 16026116 [PubMed - indexed for MEDLINE]

286: Shichi T, Okiyama R, Yokochi F, Taniguchi M, Takahashi H, Hamada I.
[Unilateral subthalamic stimulation for early-stage Parkinson's disease]
No To Shinkei. 2005 Jun;57(6):495-8. Review. Japanese.
PMID: 16026045 [PubMed - indexed for MEDLINE]

287: Abe K, Hashida G, Takagi K, Matsuo Y, Uchiyama A, Koura A, Inoue S.
[Rehabilitation for gait and activity of daily livings at home: an informed form
for Parkinson's disease patients]
No To Shinkei. 2005 Jun;57(6):481-90. Review. Japanese.
PMID: 16026043 [PubMed - indexed for MEDLINE]

288: Seutin V.
Dopaminergic neurones: much more than dopamine?
Br J Pharmacol. 2005 Sep;146(2):167-9. Review.
PMID: 16025140 [PubMed - indexed for MEDLINE]

289: Hague SM, Klaffke S, Bandmann O.
Neurodegenerative disorders: Parkinson's disease and Huntington's disease.
J Neurol Neurosurg Psychiatry. 2005 Aug;76(8):1058-63. Review.
PMID: 16024878 [PubMed - indexed for MEDLINE]

290: Dykens JA, Moos WH, Howell N.
Development of 17alpha-estradiol as a neuroprotective therapeutic agent:
rationale and results from a phase I clinical study.
Ann N Y Acad Sci. 2005 Jun;1052:116-35. Review.
PMID: 16024755 [PubMed - indexed for MEDLINE]

291: van Dijk H, Jannink MJ, Hermens HJ.
Effect of augmented feedback on motor function of the affected upper extremity in
rehabilitation patients: a systematic review of randomized controlled trials.
J Rehabil Med. 2005 Jul;37(4):202-11. Review.
PMID: 16024475 [PubMed - indexed for MEDLINE]

292: Harrower TP, Michell AW, Barker RA.
Lewy bodies in Parkinson's disease: protectors or perpetrators?
Exp Neurol. 2005 Sep;195(1):1-6. Review. No abstract available.
PMID: 16023637 [PubMed - indexed for MEDLINE]

293: Moore DJ, West AB, Dawson VL, Dawson TM.
Molecular pathophysiology of Parkinson's disease.
Annu Rev Neurosci. 2005;28:57-87. Review.
PMID: 16022590 [PubMed - indexed for MEDLINE]

294: Vu CB.
Recent advances in the design and optimization of adenosine A2A receptor
antagonists.
Curr Opin Drug Discov Devel. 2005 Jul;8(4):458-68. Review.
PMID: 16022182 [PubMed - indexed for MEDLINE]

295: Shipe WD, Wolkenberg SE, Williams DL Jr, Lindsley CW.
Recent advances in positive allosteric modulators of metabotropic glutamate
receptors.
Curr Opin Drug Discov Devel. 2005 Jul;8(4):449-57. Review.
PMID: 16022181 [PubMed - indexed for MEDLINE]

296: Ostrowski M, Izdebska M, Grzanka A, Zuryń A, Grzanka D.
[The involvement of transglutaminase 2 in autoimmunological diseases]
Postepy Hig Med Dosw (Online). 2005;59:334-9. Review. Polish.
PMID: 16012394 [PubMed - indexed for MEDLINE]

297: Salmi P, Chergui K, Fredholm BB.
Adenosine-dopamine interactions revealed in knockout mice.
J Mol Neurosci. 2005;26(2-3):239-44. Review.
PMID: 16012197 [PubMed - indexed for MEDLINE]

298: Fuxe K, Ferré S, Canals M, Torvinen M, Terasmaa A, Marcellino D, Goldberg
SR, Staines W, Jacobsen KX, Lluis C, Woods AS, Agnati LF, Franco R.
Adenosine A2A and dopamine D2 heteromeric receptor complexes and their function.
J Mol Neurosci. 2005;26(2-3):209-20. Review.
PMID: 16012194 [PubMed - indexed for MEDLINE]

299: Israel Z, Hassin-Baer S.
Subthalamic stimulation for Parkinson's disease.
Isr Med Assoc J. 2005 Jul;7(7):458-63. Review.
PMID: 16011063 [PubMed - indexed for MEDLINE]

300: Seibyl J, Jennings D, Tabamo R, Marek K.
Unique roles of SPET brain imaging in clinical and research studies. Lessons from
Parkinson's disease research.
Q J Nucl Med Mol Imaging. 2005 Jun;49(2):215-21. Review.
PMID: 16010256 [PubMed - indexed for MEDLINE]

301: Linazasoro G.
New ideas on the origin of L-dopa-induced dyskinesias: age, genes and neural
plasticity.
Trends Pharmacol Sci. 2005 Aug;26(8):391-7. Review.
PMID: 16009432 [PubMed - indexed for MEDLINE]

302: Pardo LM, van Duijn CM.
In search of genes involved in neurodegenerative disorders.
Mutat Res. 2005 Dec 30;592(1-2):89-101. Epub 2005 Jul 11. Review.
PMID: 16009383 [PubMed - indexed for MEDLINE]

303: Au WL, Calne DB.
A reassessment of the Lewy body.
Acta Neurol Taiwan. 2005 Jun;14(2):40-7. Review.
PMID: 16008161 [PubMed - indexed for MEDLINE]

304: Brotchie JM.
Nondopaminergic mechanisms in levodopa-induced dyskinesia.
Mov Disord. 2005 Aug;20(8):919-31. Review.
PMID: 16007614 [PubMed - indexed for MEDLINE]

305: Blandini F.
Neuroprotection by rasagiline: a new therapeutic approach to Parkinson's disease?
CNS Drug Rev. 2005 Summer;11(2):183-94. Review.
PMID: 16007239 [PubMed - indexed for MEDLINE]

306: Gildenberg PL.
Evolution of neuromodulation.
Stereotact Funct Neurosurg. 2005;83(2-3):71-9. Epub 2005 Jul 6. Review.
PMID: 16006778 [PubMed - indexed for MEDLINE]

307: Zhang L, Dawson VL, Dawson TM.
Role of nitric oxide in Parkinson's disease.
Pharmacol Ther. 2006 Jan;109(1-2):33-41. Epub 2005 Jul 7. Review.
PMID: 16005074 [PubMed - indexed for MEDLINE]

308: Jenner P.
Istradefylline, a novel adenosine A2A receptor antagonist, for the treatment of
Parkinson's disease.
Expert Opin Investig Drugs. 2005 Jun;14(6):729-38. Review.
PMID: 16004599 [PubMed - indexed for MEDLINE]

309: Schrag A, Lang AE.
Psychogenic movement disorders.
Curr Opin Neurol. 2005 Aug;18(4):399-404. Review.
PMID: 16003115 [PubMed - indexed for MEDLINE]

310: Snyder BJ, Olanow CW.
Stem cell treatment for Parkinson's disease: an update for 2005.
Curr Opin Neurol. 2005 Aug;18(4):376-85. Review.
PMID: 16003112 [PubMed - indexed for MEDLINE]

311: Seppi K, Schocke MF.
An update on conventional and advanced magnetic resonance imaging techniques in
the differential diagnosis of neurodegenerative parkinsonism.
Curr Opin Neurol. 2005 Aug;18(4):370-5. Review.
PMID: 16003111 [PubMed - indexed for MEDLINE]

312: Gasser T.
Genetics of Parkinson's disease.
Curr Opin Neurol. 2005 Aug;18(4):363-9. Review.
PMID: 16003110 [PubMed - indexed for MEDLINE]

313: Dezawa M.
[Specific induction of neurons and Schwann cells from bone marrow stromal cells
and application to neurodegenerative diseases]
No Shinkei Geka. 2005 Jul;33(7):645-9. Review. Japanese. No abstract available.
PMID: 16001805 [PubMed - indexed for MEDLINE]

314: Scott M, Chowdhury M.
Pregnancy in Parkinson's disease: unique case report and review of the
literature.
Mov Disord. 2005 Aug;20(8):1078-9. Review. No abstract available.
PMID: 16001415 [PubMed - indexed for MEDLINE]

315: Papapetropoulos S, Mash DC.
Psychotic symptoms in Parkinson's disease. From description to etiology.
J Neurol. 2005 Jul;252(7):753-64. Review.
PMID: 15999234 [PubMed - indexed for MEDLINE]

316: Seppi K, Schocke MF, Wenning GK, Poewe W.
How to diagnose MSA early: the role of magnetic resonance imaging.
J Neural Transm. 2005 Dec;112(12):1625-34. Epub 2005 Jul 6. Review.
PMID: 15997415 [PubMed - indexed for MEDLINE]

317: Adler CH, Thorpy MJ.
Sleep issues in Parkinson's disease.
Neurology. 2005 Jun 28;64(12 Suppl 3):S12-20. Review.
PMID: 15994219 [PubMed - indexed for MEDLINE]

318: Haour F.
Mechanisms of the placebo effect and of conditioning.
Neuroimmunomodulation. 2005;12(4):195-200. Review.
PMID: 15990450 [PubMed - indexed for MEDLINE]

319: Chaudhuri KR, Yates L, Martinez-Martin P.
The non-motor symptom complex of Parkinson's disease: a comprehensive assessment
is essential.
Curr Neurol Neurosci Rep. 2005 Jul;5(4):275-83. Review.
PMID: 15987611 [PubMed - indexed for MEDLINE]

320: Dejda A, Sokołowska P, Nowak JZ.
Neuroprotective potential of three neuropeptides PACAP, VIP and PHI.
Pharmacol Rep. 2005 May-Jun;57(3):307-20. Review.
PMID: 15985713 [PubMed - indexed for MEDLINE]

321: Jankovic J.
Searching for a relationship between manganese and welding and Parkinson's
disease.
Neurology. 2005 Jun 28;64(12):2021-8. Review.
PMID: 15985567 [PubMed - indexed for MEDLINE]

322: Hows J.
Adult stem cell therapy beyond haemopoietic stem cell transplantation? An update.
Transpl Immunol. 2005 Aug;14(3-4):221-3. Epub 2005 Apr 26. Review.
PMID: 15982566 [PubMed - indexed for MEDLINE]

323: Fukuyama H.
[Neuroimaging present and future]
No To Shinkei. 2005 May;57(5):387-96. Review. Japanese. No abstract available.
PMID: 15981638 [PubMed - indexed for MEDLINE]

324: Pinna A, Wardas J, Simola N, Morelli M.
New therapies for the treatment of Parkinson's disease: adenosine A2A receptor
antagonists.
Life Sci. 2005 Nov 12;77(26):3259-67. Epub 2005 Jun 23. Review.
PMID: 15979104 [PubMed - indexed for MEDLINE]

325: Sarkar D, Fisher PB.
Molecular mechanisms of aging-associated inflammation.
Cancer Lett. 2006 May 8;236(1):13-23. Epub 2005 Jun 22. Review.
PMID: 15978720 [PubMed - indexed for MEDLINE]

326: Burkhard PR, Villemure JG, Vingerhoets FJ.
[Current treatment of Parkinson's disease: problems and controversies]
Rev Med Suisse. 2005 May 4;1(18):1214, 1216-9. Review. French.
PMID: 15977710 [PubMed - indexed for MEDLINE]

327: Larsen JP.
[Diagnosis and treatment of patients with parkinsonism in nursing homes: how to
improve quality?]
Tidsskr Nor Laegeforen. 2005 Jun 16;125(12):1669-71. Review. Norwegian.
PMID: 15976838 [PubMed - indexed for MEDLINE]

328: van Muiswinkel FL, Kuiperij HB.
The Nrf2-ARE Signalling pathway: promising drug target to combat oxidative stress
in neurodegenerative disorders.
Curr Drug Targets CNS Neurol Disord. 2005 Jun;4(3):267-81. Review.
PMID: 15975029 [PubMed - indexed for MEDLINE]

329: McCown TJ.
Adeno-associated virus (AAV) vectors in the CNS.
Curr Gene Ther. 2005 Jun;5(3):333-8. Review.
PMID: 15975010 [PubMed - indexed for MEDLINE]

330: Casetta I, Govoni V, Granieri E.
Oxidative stress, antioxidants and neurodegenerative diseases.
Curr Pharm Des. 2005;11(16):2033-52. Review.
PMID: 15974957 [PubMed - indexed for MEDLINE]

331: Hauser RA, Schwarzschild MA.
Adenosine A2A receptor antagonists for Parkinson's disease: rationale,
therapeutic potential and clinical experience.
Drugs Aging. 2005;22(6):471-82. Review.
PMID: 15974638 [PubMed - indexed for MEDLINE]

332: Holden MK.
Virtual environments for motor rehabilitation: review.
Cyberpsychol Behav. 2005 Jun;8(3):187-211; discussion 212-9. Review.
PMID: 15971970 [PubMed - indexed for MEDLINE]

333: Hoffner G, Djian P.
Transglutaminase and diseases of the central nervous system.
Front Biosci. 2005 Sep 1;10:3078-92. Review.
PMID: 15970562 [PubMed - indexed for MEDLINE]

334: Cole K, Vaughan FL.
The feasibility of using cognitive behaviour therapy for depression associated
with Parkinson's disease: a literature review.
Parkinsonism Relat Disord. 2005 Aug;11(5):269-76. Review.
PMID: 15970452 [PubMed - indexed for MEDLINE]

335: Amantea D, Russo R, Bagetta G, Corasaniti MT.
From clinical evidence to molecular mechanisms underlying neuroprotection
afforded by estrogens.
Pharmacol Res. 2005 Aug;52(2):119-32. Review.
PMID: 15967377 [PubMed - indexed for MEDLINE]

336: Romeo MJ, Espina V, Lowenthal M, Espina BH, Petricoin EF 3rd, Liotta LA.
CSF proteome: a protein repository for potential biomarker identification.
Expert Rev Proteomics. 2005 Jan;2(1):57-70. Review.
PMID: 15966853 [PubMed - indexed for MEDLINE]

337: Tison F, Ghorayeb I.
[Parkinson's disease and associated disorders]
Rev Prat. 2005 Apr 15;55(7):741-7. Review. French.
PMID: 15966417 [PubMed - indexed for MEDLINE]

338: Fénelon G.
[Management of psychiatric complications of Parkinson's disease]
Rev Prat. 2005 Apr 15;55(7):733-9. Review. French.
PMID: 15966416 [PubMed - indexed for MEDLINE]

339: Destee A.
[Therapeutic strategies for Parkinson's disease]
Rev Prat. 2005 Apr 15;55(7):723-32. Review. French.
PMID: 15966415 [PubMed - indexed for MEDLINE]

340: Thobois S, Broussolle E.
[Circumstances of Parkinson's disease diagnosis]
Rev Prat. 2005 Apr 15;55(7):717-22. Review. French.
PMID: 15966414 [PubMed - indexed for MEDLINE]

341: Fénelon G.
[Parkinson's disease: dealing with all dimensions of the disease]
Rev Prat. 2005 Apr 15;55(7):714-6. Review. French. No abstract available.
PMID: 15966413 [PubMed - indexed for MEDLINE]

342: Arenas E.
Engineering a dopaminergic phenotype in stem/precursor cells: role of Nurr1,
glia-derived signals, and Wnts.
Ann N Y Acad Sci. 2005 May;1049:51-66. Review.
PMID: 15965107 [PubMed - indexed for MEDLINE]

343: von Campenhausen S, Bornschein B, Wick R, Bötzel K, Sampaio C, Poewe W,
Oertel W, Siebert U, Berger K, Dodel R.
Prevalence and incidence of Parkinson's disease in Europe.
Eur Neuropsychopharmacol. 2005 Aug;15(4):473-90. Review.
PMID: 15963700 [PubMed - indexed for MEDLINE]

344: Ashour R, Tintner R, Jankovic J.
Striatal deformities of the hand and foot in Parkinson's disease.
Lancet Neurol. 2005 Jul;4(7):423-31. Review.
PMID: 15963445 [PubMed - indexed for MEDLINE]

345: Shults CW.
Therapeutic role of coenzyme Q(10) in Parkinson's disease.
Pharmacol Ther. 2005 Jul;107(1):120-30. Epub 2005 Apr 21. Review.
PMID: 15963354 [PubMed - indexed for MEDLINE]

346: Picada JN, Roesler R, Henriques JA.
Genotoxic, neurotoxic and neuroprotective activities of apomorphine and its
oxidized derivative 8-oxo-apomorphine.
Braz J Med Biol Res. 2005 Apr;38(4):477-86. Epub 2005 Apr 13. Review.
PMID: 15962173 [PubMed - indexed for MEDLINE]

347: Li C, Bowles DE, van Dyke T, Samulski RJ.
Adeno-associated virus vectors: potential applications for cancer gene therapy.
Cancer Gene Ther. 2005 Dec;12(12):913-25. Review.
PMID: 15962012 [PubMed - indexed for MEDLINE]

348: Walker DG, Lue LF.
Investigations with cultured human microglia on pathogenic mechanisms of
Alzheimer's disease and other neurodegenerative diseases.
J Neurosci Res. 2005 Aug 1;81(3):412-25. Review.
PMID: 15957156 [PubMed - indexed for MEDLINE]

349: Houghton PJ, Howes MJ.
Natural products and derivatives affecting neurotransmission relevant to
Alzheimer's and Parkinson's disease.
Neurosignals. 2005;14(1-2):6-22. Review.
PMID: 15956811 [PubMed - indexed for MEDLINE]

350: Singleton AB.
Altered alpha-synuclein homeostasis causing Parkinson's disease: the potential
roles of dardarin.
Trends Neurosci. 2005 Aug;28(8):416-21. Review.
PMID: 15955578 [PubMed - indexed for MEDLINE]

351: Weintraub D, Morales KH, Moberg PJ, Bilker WB, Balderston C, Duda JE, Katz
IR, Stern MB.
Antidepressant studies in Parkinson's disease: a review and meta-analysis.
Mov Disord. 2005 Sep;20(9):1161-9. Review.
PMID: 15954137 [PubMed - indexed for MEDLINE]

352: Kim SU, de Vellis J.
Microglia in health and disease.
J Neurosci Res. 2005 Aug 1;81(3):302-13. Review.
PMID: 15954124 [PubMed - indexed for MEDLINE]

353: Liu Y, Yang H.
Environmental toxins and alpha-synuclein in Parkinson's disease.
Mol Neurobiol. 2005;31(1-3):273-82. Review.
PMID: 15953827 [PubMed - indexed for MEDLINE]

354: Yu S, Uéda K, Chan P.
Alpha-synuclein and dopamine metabolism.
Mol Neurobiol. 2005;31(1-3):243-54. Review.
PMID: 15953825 [PubMed - indexed for MEDLINE]

355: Doggrell SA.
Recent important trials of pharmacotherapy in Parkinson's disease.
Expert Opin Pharmacother. 2005 Jun;6(6):1025-8. Review.
PMID: 15952930 [PubMed - indexed for MEDLINE]

356: Cookson MR.
The biochemistry of Parkinson's disease.
Annu Rev Biochem. 2005;74:29-52. Review.
PMID: 15952880 [PubMed - indexed for MEDLINE]

357: Hatakeyama S.
[Neurodegenerative diseases regulated by ubiquitin-proteasome system]
Seikagaku. 2005 May;77(5):389-99. Review. Japanese. No abstract available.
PMID: 15952328 [PubMed - indexed for MEDLINE]

358: Nicolaus BJ.
A critical review of the function of neuromelanin and an attempt to provide a
unified theory.
Med Hypotheses. 2005;65(4):791-6. Review.
PMID: 15949901 [PubMed - indexed for MEDLINE]

359: Winkler J, Hescheler J, Sachinidis A.
Embryonic stem cells for basic research and potential clinical applications in
cardiology.
Biochim Biophys Acta. 2005 May 30;1740(2):240-8. Epub 2004 Dec 9. Review.
PMID: 15949691 [PubMed - indexed for MEDLINE]

360: Barrett AM.
Is it Alzheimer's disease or something else? 10 disorders that may feature
impaired memory and cognition.
Postgrad Med. 2005 May;117(5):47-53. Review.
PMID: 15948369 [PubMed - indexed for MEDLINE]

361: Mercuri NB, Bernardi G.
The 'magic' of L-dopa: why is it the gold standard Parkinson's disease therapy?
Trends Pharmacol Sci. 2005 Jul;26(7):341-4. Review.
PMID: 15936832 [PubMed - indexed for MEDLINE]

362: Maher P.
The effects of stress and aging on glutathione metabolism.
Ageing Res Rev. 2005 May;4(2):288-314. Review.
PMID: 15936251 [PubMed - indexed for MEDLINE]

363: Weiss B.
Economic implications of manganese neurotoxicity.
Neurotoxicology. 2006 May;27(3):362-8. Epub 2005 Jun 3. Review.
PMID: 15936082 [PubMed - indexed for MEDLINE]

364: Cools R.
Dopaminergic modulation of cognitive function-implications for L-DOPA treatment
in Parkinson's disease.
Neurosci Biobehav Rev. 2006;30(1):1-23. Epub 2005 Jun 1. Review.
PMID: 15935475 [PubMed - indexed for MEDLINE]

365: Hoyt BD.
Sleep in patients with neurologic and psychiatric disorders.
Prim Care. 2005 Jun;32(2):535-48, ix. Review.
PMID: 15935199 [PubMed - indexed for MEDLINE]

366: Manni R.
Rapid eye movement sleep, non-rapid eye movement sleep, dreams, and
hallucinations.
Curr Psychiatry Rep. 2005 Jun;7(3):196-200. Review.
PMID: 15935133 [PubMed - indexed for MEDLINE]

367: Muramatsu S, Tsukada H, Nakano I, Ozawa K.
Gene therapy for Parkinson's disease using recombinant adeno-associated viral
vectors.
Expert Opin Biol Ther. 2005 May;5(5):663-71. Review.
PMID: 15934841 [PubMed - indexed for MEDLINE]

368: Dezawa M, Hoshino M, Ide C.
Treatment of neurodegenerative diseases using adult bone marrow stromal
cell-derived neurons.
Expert Opin Biol Ther. 2005 Apr;5(4):427-35. Review.
PMID: 15934822 [PubMed - indexed for MEDLINE]

369: Pelissier J, Benaim C, Bonin-Koang KY, Castelnovo G, Perennou D.
[Assessment of idiopathic Parkinson's disease in physical medicine and
rehabilitation]
Ann Readapt Med Phys. 2005 Jul;48(6):341-5. Epub 2005 Apr 20. Review. French.
PMID: 15932779 [PubMed - indexed for MEDLINE]

370: Zadikoff C, Lang AE.
Apraxia in movement disorders.
Brain. 2005 Jul;128(Pt 7):1480-97. Epub 2005 Jun 1. Review.
PMID: 15930045 [PubMed - indexed for MEDLINE]

371: Picconi B, Pisani A, Barone I, Bonsi P, Centonze D, Bernardi G, Calabresi P.
Pathological synaptic plasticity in the striatum: implications for Parkinson's
disease.
Neurotoxicology. 2005 Oct;26(5):779-83. Epub 2005 May 31. Review.
PMID: 15927256 [PubMed - indexed for MEDLINE]

372: Smidt N, de Vet HC, Bouter LM, Dekker J, Arendzen JH, de Bie RA,
Bierma-Zeinstra SM, Helders PJ, Keus SH, Kwakkel G, Lenssen T, Oostendorp RA,
Ostelo RW, Reijman M, Terwee CB, Theunissen C, Thomas S, van Baar ME, van 't Hul
A, van Peppen RP, Verhagen A, van der Windt DA; Exercise Therapy Group.
Effectiveness of exercise therapy: a best-evidence summary of systematic reviews.
Aust J Physiother. 2005;51(2):71-85. Review.
PMID: 15924510 [PubMed - indexed for MEDLINE]

373: Charpentier P, Dauphin A, Stojkovic T, Cotten A, Hurtevent JF, Maurage CA,
Thévenon A, Destée A, Defebvre L.
[Parkinson's disease, progressive lumbar kyphosis and focal paraspinal myositis]
Rev Neurol (Paris). 2005 Apr;161(4):459-63. Review. French.
PMID: 15924083 [PubMed - indexed for MEDLINE]

374: Thobois S, Broussolle E, Remy P.
[Advantages and limitations in the assessment of neuroprotective treatment of
Parkinson's disease by functional imaging]
Rev Neurol (Paris). 2005 Apr;161(4):385-93. Review. French.
PMID: 15924074 [PubMed - indexed for MEDLINE]

375: Guatteo E, Marinelli S, Geracitano R, Tozzi A, Federici M, Bernardi G,
Mercuri NB.
Dopamine-containing neurons are silenced by energy deprivation: a defensive
response or beginning of cell death?
Neurotoxicology. 2005 Oct;26(5):857-68. Review.
PMID: 15922452 [PubMed - indexed for MEDLINE]

376: Davidsson P, Sjögren M.
The use of proteomics in biomarker discovery in neurodegenerative diseases.
Dis Markers. 2005;21(2):81-92. Review.
PMID: 15920295 [PubMed - indexed for MEDLINE]

377: Hamani C, Richter E, Schwalb JM, Lozano AM.
Bilateral subthalamic nucleus stimulation for Parkinson's disease: a systematic
review of the clinical literature.
Neurosurgery. 2005 Jun;56(6):1313-21; discussion 1321-4. Review.
PMID: 15918948 [PubMed - indexed for MEDLINE]

378: Surmeier DJ, Mercer JN, Chan CS.
Autonomous pacemakers in the basal ganglia: who needs excitatory synapses anyway?
Curr Opin Neurobiol. 2005 Jun;15(3):312-8. Review.
PMID: 15916893 [PubMed - indexed for MEDLINE]

379: Enck P, Klosterhalfen S.
The placebo response in functional bowel disorders: perspectives and putative
mechanisms.
Neurogastroenterol Motil. 2005 Jun;17(3):325-31. Review. Erratum in:
Neurogastroenterol Motil. 2005 Aug;17(4):600.
PMID: 15916619 [PubMed - indexed for MEDLINE]

380: West AB, Dawson VL, Dawson TM.
To die or grow: Parkinson's disease and cancer.
Trends Neurosci. 2005 Jul;28(7):348-52. Review.
PMID: 15913799 [PubMed - indexed for MEDLINE]

381: Koh DW, Dawson TM, Dawson VL.
Mediation of cell death by poly(ADP-ribose) polymerase-1.
Pharmacol Res. 2005 Jul;52(1):5-14. Review.
PMID: 15911329 [PubMed - indexed for MEDLINE]

382: van der Mast RC, Huyse FJ, Rosier PF.
[Guideline 'Delirium']
Ned Tijdschr Geneeskd. 2005 May 7;149(19):1027-32. Review. Dutch.
PMID: 15909390 [PubMed - indexed for MEDLINE]

383: Schrag A.
Entacapone in the treatment of Parkinson's disease.
Lancet Neurol. 2005 Jun;4(6):366-70. Review.
PMID: 15907741 [PubMed - indexed for MEDLINE]

384: Stewart RM, Desaloms JM, Sanghera MK.
Stimulation of the subthalamic nucleus for the treatment of Parkinson's disease:
postoperative management, programming, and rehabilitation.
J Neurosci Nurs. 2005 Apr;37(2):108-14. Review.
PMID: 15902954 [PubMed - indexed for MEDLINE]

385: Ruiz-Sánchez de León JM, Fernández-Guinea S.
[Visuoperceptual processing in Parkinson's disease: from the retina to the
frontal cortex]
Rev Neurol. 2005 May 1-15;40(9):557-62. Review. Spanish.
PMID: 15898018 [PubMed - indexed for MEDLINE]

386: Eckert T, Eidelberg D.
Neuroimaging and therapeutics in movement disorders.
NeuroRx. 2005 Apr;2(2):361-71. Review.
PMID: 15897956 [PubMed - indexed for MEDLINE]

387: Calabrese V, Lodi R, Tonon C, D'Agata V, Sapienza M, Scapagnini G,
Mangiameli A, Pennisi G, Stella AM, Butterfield DA.
Oxidative stress, mitochondrial dysfunction and cellular stress response in
Friedreich's ataxia.
J Neurol Sci. 2005 Jun 15;233(1-2):145-62. Review.
PMID: 15896810 [PubMed - indexed for MEDLINE]

388: Corey S.
Recent developments in the therapeutic potential of cannabinoids.
P R Health Sci J. 2005 Mar;24(1):19-26. Review.
PMID: 15895873 [PubMed - indexed for MEDLINE]

389: Arnulf I.
Excessive daytime sleepiness in parkinsonism.
Sleep Med Rev. 2005 Jun;9(3):185-200. Epub 2005 Apr 26. Review.
PMID: 15893249 [PubMed - indexed for MEDLINE]

390: Castro A, Valldeoriola F, Linazasoro G, Rodriguez-Oroz MC, Stochi F, Marin
C, Rodriguez M, Vaamonde J, Jenner P, Alvarez L, Pavon N, Macias R, Luquin MR,
Hernandez B, Grandas F, Gimenez-Roldan S, Tolosa E, Obeso JA.
[Optimization of use of levodopa in Parkinson's disease: role of
levodopa-carbidopa-entacapone combination.]
Neurologia. 2005 May;20(4):180-8. Review. Spanish.
PMID: 15891947 [PubMed - indexed for MEDLINE]

391: Shults CW.
Antioxidants as therapy for Parkinson's disease.
Antioxid Redox Signal. 2005 May-Jun;7(5-6):694-700. Review. No abstract
available.
PMID: 15890014 [PubMed - indexed for MEDLINE]

392: Przedborski S, Ischiropoulos H.
Reactive oxygen and nitrogen species: weapons of neuronal destruction in models
of Parkinson's disease.
Antioxid Redox Signal. 2005 May-Jun;7(5-6):685-93. Review.
PMID: 15890013 [PubMed - indexed for MEDLINE]

393: Norris EH, Giasson BI.
Role of oxidative damage in protein aggregation associated with Parkinson's
disease and related disorders.
Antioxid Redox Signal. 2005 May-Jun;7(5-6):672-84. Review.
PMID: 15890012 [PubMed - indexed for MEDLINE]

394: Kovács T, Szirmai I, Papp M.
[Clinico-pathology and differential diagnosis of Binswanger's disease]
Ideggyogy Sz. 2005 Mar 20;58(3-4):78-87. Review. Hungarian.
PMID: 15887411 [PubMed - indexed for MEDLINE]

395: Hirsch EC, Hunot S, Hartmann A.
Neuroinflammatory processes in Parkinson's disease.
Parkinsonism Relat Disord. 2005 Jun;11 Suppl 1:S9-S15. Review.
PMID: 15885630 [PubMed - indexed for MEDLINE]

396: Mori H.
Pathological substrate of dementia in Parkinson's disease--its relation to DLB
and DLBD.
Parkinsonism Relat Disord. 2005 Jun;11 Suppl 1:S41-5. Review.
PMID: 15885628 [PubMed - indexed for MEDLINE]

397: Calne D.
A definition of Parkinson's disease.
Parkinsonism Relat Disord. 2005 Jun;11 Suppl 1:S39-40. Review.
PMID: 15885627 [PubMed - indexed for MEDLINE]

398: Takahashi H, Wakabayashi K.
Controversy: is Parkinson's disease a single disease entity? Yes.
Parkinsonism Relat Disord. 2005 Jun;11 Suppl 1:S31-7. Epub 2005 Apr 20. Review.
PMID: 15885626 [PubMed - indexed for MEDLINE]

399: Przedborski S.
Pathogenesis of nigral cell death in Parkinson's disease.
Parkinsonism Relat Disord. 2005 Jun;11 Suppl 1:S3-7. Review.
PMID: 15885625 [PubMed - indexed for MEDLINE]

400: Guigoni C, Aubert I, Li Q, Gurevich VV, Benovic JL, Ferry S, Mach U, Stark
H, Leriche L, Håkansson K, Bioulac BH, Gross CE, Sokoloff P, Fisone G, Gurevich
EV, Bloch B, Bezard E.
Pathogenesis of levodopa-induced dyskinesia: focus on D1 and D3 dopamine
receptors.
Parkinsonism Relat Disord. 2005 Jun;11 Suppl 1:S25-9. Review.
PMID: 15885624 [PubMed - indexed for MEDLINE]

401: Oyanagi K.
The nature of the parkinsonism-dementia complex and amyotrophic lateral sclerosis
of Guam and magnesium deficiency.
Parkinsonism Relat Disord. 2005 Jun;11 Suppl 1:S17-23. Review.
PMID: 15885623 [PubMed - indexed for MEDLINE]

402: Thobois S, Delamarre-Damier F, Derkinderen P.
Treatment of motor dysfunction in Parkinson's disease: an overview.
Clin Neurol Neurosurg. 2005 Jun;107(4):269-81. Review.
PMID: 15885384 [PubMed - indexed for MEDLINE]

403: Farsang M, Takáts A, Szirmai I, Kovács T.
[Clinical features of corticobasal degeneration]
Ideggyogy Sz. 2005 Jan 20;58(1-2):45-51. Review. Hungarian.
PMID: 15884398 [PubMed - indexed for MEDLINE]

404: Konitsiotis S.
Novel pharmacological strategies for motor complications in Parkinson's disease.
Expert Opin Investig Drugs. 2005 Apr;14(4):377-92. Review.
PMID: 15882115 [PubMed - indexed for MEDLINE]

405: Boules M, Fredrickson P, Richelson E.
Neurotensin agonists as an alternative to antipsychotics.
Expert Opin Investig Drugs. 2005 Apr;14(4):359-69. Review.
PMID: 15882113 [PubMed - indexed for MEDLINE]

406: Bressan RA, Crippa JA.
The role of dopamine in reward and pleasure behaviour--review of data from
preclinical research.
Acta Psychiatr Scand Suppl. 2005;(427):14-21. Review.
PMID: 15877719 [PubMed - indexed for MEDLINE]

407: Maidment ID, Fox C, Boustani M.
A review of studies describing the use of acetyl cholinesterase inhibitors in
Parkinson's disease dementia.
Acta Psychiatr Scand. 2005 Jun;111(6):403-9. Review.
PMID: 15877706 [PubMed - indexed for MEDLINE]

408: Fricchione G, Stefano GB.
Placebo neural systems: nitric oxide, morphine and the dopamine brain reward and
motivation circuitries.
Med Sci Monit. 2005 May;11(5):MS54-65. Epub 2005 Apr 28. Review.
PMID: 15874901 [PubMed - indexed for MEDLINE]

409: Hald A, Lotharius J.
Oxidative stress and inflammation in Parkinson's disease: is there a causal link?
Exp Neurol. 2005 Jun;193(2):279-90. Review.
PMID: 15869932 [PubMed - indexed for MEDLINE]

410: Koh DW, Dawson TM, Dawson VL.
Poly(ADP-ribosyl)ation regulation of life and death in the nervous system.
Cell Mol Life Sci. 2005 Apr;62(7-8):760-8. Review.
PMID: 15868401 [PubMed - indexed for MEDLINE]

411: O'Neill MJ, Murray TK, Clay MP, Lindstrom T, Yang CR, Nisenbaum ES.
LY503430: pharmacology, pharmacokinetics, and effects in rodent models of
Parkinson's disease.
CNS Drug Rev. 2005 Spring;11(1):77-96. Review.
PMID: 15867954 [PubMed - indexed for MEDLINE]

412: Weller C, Oxlade N, Dobbs SM, Dobbs RJ, Charlett A, Bjarnason IT.
Role of inflammation in gastrointestinal tract in aetiology and pathogenesis of
idiopathic parkinsonism.
FEMS Immunol Med Microbiol. 2005 May 1;44(2):129-35. Review.
PMID: 15866206 [PubMed - indexed for MEDLINE]

413: Hatano Y, Ri G, Hattori N, Mizuno Y.
[Gene abnormalities in Parkinson disease]
Nippon Naika Gakkai Zasshi. 2005 Apr 10;94(4):775-81. Review. Japanese. No
abstract available.
PMID: 15865010 [PubMed - indexed for MEDLINE]

414: Steultjens EM, Dekker J, Bouter LM, Leemrijse CJ, van den Ende CH.
Evidence of the efficacy of occupational therapy in different conditions: an
overview of systematic reviews.
Clin Rehabil. 2005 May;19(3):247-54. Review.
PMID: 15859525 [PubMed - indexed for MEDLINE]

415: Yoshimura N, Kawamura M.
[Impairment of social cognition in Parkinson's disease]
No To Shinkei. 2005 Feb;57(2):107-13. Review. Japanese.
PMID: 15856756 [PubMed - indexed for MEDLINE]

416: Ishida Y.
[Psychiatric symptoms of Parkinson's disease--an overview from the studies on
dopaminergic nerves]
Seishin Shinkeigaku Zasshi. 2005;107(3):290-3. Review. Japanese. No abstract
available.
PMID: 15856754 [PubMed - indexed for MEDLINE]

417: Everse J, Coates PW.
Role of peroxidases in Parkinson disease: a hypothesis.
Free Radic Biol Med. 2005 May 15;38(10):1296-310. Review.
PMID: 15855048 [PubMed - indexed for MEDLINE]

418: Kakar RS, Kushida CA.
Ropinirole in the treatment of restless legs syndrome.
Expert Rev Neurother. 2005 Jan;5(1):35-42. Review.
PMID: 15853472 [PubMed - indexed for MEDLINE]

419: Mandel S, Weinreb O, Amit T, Youdim MB.
Mechanism of neuroprotective action of the anti-Parkinson drug rasagiline and its
derivatives.
Brain Res Brain Res Rev. 2005 Apr;48(2):379-87. Review.
PMID: 15850677 [PubMed - indexed for MEDLINE]

420: Marchetti B, Serra PA, Tirolo C, L'episcopo F, Caniglia S, Gennuso F, Testa
N, Miele E, Desole S, Barden N, Morale MC.
Glucocorticoid receptor-nitric oxide crosstalk and vulnerability to experimental
parkinsonism: pivotal role for glia-neuron interactions.
Brain Res Brain Res Rev. 2005 Apr;48(2):302-21. Review.
PMID: 15850669 [PubMed - indexed for MEDLINE]

421: Fioravanti M, Yanagi M.
Cytidinediphosphocholine (CDP-choline) for cognitive and behavioural disturbances
associated with chronic cerebral disorders in the elderly.
Cochrane Database Syst Rev. 2005 Apr 18;(2):CD000269. Review.
PMID: 15846601 [PubMed - indexed for MEDLINE]

422: Bannon MJ.
The dopamine transporter: role in neurotoxicity and human disease.
Toxicol Appl Pharmacol. 2005 May 1;204(3):355-60. Review.
PMID: 15845424 [PubMed - indexed for MEDLINE]

423: Wright AF.
Neurogenetics II: complex disorders.
J Neurol Neurosurg Psychiatry. 2005 May;76(5):623-31. Review.
PMID: 15834017 [PubMed - indexed for MEDLINE]

424: del Barrio JL, de Pedro-Cuesta J, Boix R, Acosta J, Bergareche A,
Bermejo-Pareja F, Gabriel R, García de Yébenes MJ, García FJ, López-Pousa S,
Manubens JM, Mateos R, Matías-Guiu J, Olivé JM, Reñé R, Rodríguez F, Saz P.
Dementia, stroke and Parkinson's disease in Spanish populations: a review of
door-to-door prevalence surveys.
Neuroepidemiology. 2005;24(4):179-88. Epub 2005 Apr 12. Review.
PMID: 15832058 [PubMed - indexed for MEDLINE]

425: Kusaka H.
[Clinical description of Parkinson's disease]
Nippon Naika Gakkai Zasshi. 2005 Mar 10;94(3):497-501. Review. Japanese. No
abstract available.
PMID: 15830525 [PubMed - indexed for MEDLINE]

426: Allam MF, Del Castillo AS, Navajas RF.
Parkinson's disease risk factors: genetic, environmental, or both?
Neurol Res. 2005 Mar;27(2):206-8. Review.
PMID: 15829184 [PubMed - indexed for MEDLINE]

427: Takeshita S, Kurisu K, Trop L, Arita K, Akimitsu T, Verhoeff NP.
Effect of subthalamic stimulation on mood state in Parkinson's disease:
evaluation of previous facts and problems.
Neurosurg Rev. 2005 Jul;28(3):179-86; discussion 187. Epub 2005 Apr 13. Review.
PMID: 15827764 [PubMed - indexed for MEDLINE]

428: Lim E.
A walk through the management of Parkinson s disease.
Ann Acad Med Singapore. 2005 Mar;34(2):188-95. Review.
PMID: 15827667 [PubMed - indexed for MEDLINE]

429: Andreasen N, Blennow K.
CSF biomarkers for mild cognitive impairment and early Alzheimer's disease.
Clin Neurol Neurosurg. 2005 Apr;107(3):165-73. Review.
PMID: 15823670 [PubMed - indexed for MEDLINE]

430: Olanow CW, Jankovic J.
Neuroprotective therapy in Parkinson's disease and motor complications: a search
for a pathogenesis-targeted, disease-modifying strategy.
Mov Disord. 2005;20 Suppl 11:S3-10. Review.
PMID: 15822111 [PubMed - indexed for MEDLINE]

431: Jankovic J.
Motor fluctuations and dyskinesias in Parkinson's disease: clinical
manifestations.
Mov Disord. 2005;20 Suppl 11:S11-6. Review.
PMID: 15822109 [PubMed - indexed for MEDLINE]

432: Widnell K.
Pathophysiology of motor fluctuations in Parkinson's disease.
Mov Disord. 2005;20 Suppl 11:S17-22. Review.
PMID: 15822108 [PubMed - indexed for MEDLINE]

433: Widnell KL, Comella C.
Role of COMT inhibitors and dopamine agonists in the treatment of motor
fluctuations.
Mov Disord. 2005;20 Suppl 11:S30-7. Review.
PMID: 15822107 [PubMed - indexed for MEDLINE]

434: Adler CH.
Nonmotor complications in Parkinson's disease.
Mov Disord. 2005;20 Suppl 11:S23-9. Review.
PMID: 15822106 [PubMed - indexed for MEDLINE]

435: Waters C.
Other pharmacological treatments for motor complications and dyskinesias.
Mov Disord. 2005;20 Suppl 11:S38-44. Review.
PMID: 15822104 [PubMed - indexed for MEDLINE]

436: Metman LV, O'Leary ST.
Role of surgery in the treatment of motor complications.
Mov Disord. 2005;20 Suppl 11:S45-56. Review.
PMID: 15822076 [PubMed - indexed for MEDLINE]

437: Kanner AM.
Should neurologists be trained to recognize and treat comorbid depression of
neurologic disorders? Yes.
Epilepsy Behav. 2005 May;6(3):303-11. Review.
PMID: 15820336 [PubMed - indexed for MEDLINE]

438: Goetz CG, Poewe W, Rascol O, Sampaio C.
Evidence-based medical review update: pharmacological and surgical treatments of
Parkinson's disease: 2001 to 2004.
Mov Disord. 2005 May;20(5):523-39. Review.
PMID: 15818599 [PubMed - indexed for MEDLINE]

439: Achem SR, Devault KR.
Dysphagia in aging.
J Clin Gastroenterol. 2005 May-Jun;39(5):357-71. Review.
PMID: 15815202 [PubMed - indexed for MEDLINE]

440: Nikolaus T.
[Gait, balance and falls--causes and consequences]
Dtsch Med Wochenschr. 2005 Apr 15;130(15):958-60; quiz 965-8. Review. German. No
abstract available.
PMID: 15812721 [PubMed - indexed for MEDLINE]

441: Fornai F, Soldani P, Lazzeri G, di Poggio AB, Biagioni F, Fulceri F, Batini
S, Ruggieri S, Paparelli A.
Neuronal inclusions in degenerative disorders Do they represent static features
or a key to understand the dynamics of the disease?
Brain Res Bull. 2005 Apr 30;65(4):275-90. Review.
PMID: 15811592 [PubMed - indexed for MEDLINE]

442: Hanagasi HA, Emre M.
Treatment of behavioural symptoms and dementia in Parkinson's disease.
Fundam Clin Pharmacol. 2005 Apr;19(2):133-46. Review.
PMID: 15810893 [PubMed - indexed for MEDLINE]

443: Döbrössy MD, Dunnett SB.
Optimising plasticity: environmental and training associated factors in
transplant-mediated brain repair.
Rev Neurosci. 2005;16(1):1-21. Review.
PMID: 15810651 [PubMed - indexed for MEDLINE]

444: Garcia L, D'Alessandro G, Bioulac B, Hammond C.
High-frequency stimulation in Parkinson's disease: more or less?
Trends Neurosci. 2005 Apr;28(4):209-16. Review.
PMID: 15808356 [PubMed - indexed for MEDLINE]

445: Ohta S.
[Study of Parkinson's disease-causing mechanism and development of
anti-Parkinson's disease drugs using endogenous substances in brain]
Nihon Shinkei Seishin Yakurigaku Zasshi. 2005 Feb;25(1):39-42. Review. Japanese.
PMID: 15796069 [PubMed - indexed for MEDLINE]

446: Mizuno Y.
[Studies on pathogenesis of Parkinson's disease]
Nippon Naika Gakkai Zasshi. 2005 Feb 20;94 Suppl:66-70. Review. Japanese. No
abstract available.
PMID: 15796059 [PubMed - indexed for MEDLINE]

447: Schadt CR, Duffis EI, Charles PD.
Pharmacological treatment of disabling tremor.
Expert Opin Pharmacother. 2005 Mar;6(3):419-28. Review.
PMID: 15794733 [PubMed - indexed for MEDLINE]

448: Ebadi M, Brown-Borg H, El Refaey H, Singh BB, Garrett S, Shavali S, Sharma
SK.
Metallothionein-mediated neuroprotection in genetically engineered mouse models
of Parkinson's disease.
Brain Res Mol Brain Res. 2005 Mar 24;134(1):67-75. Review.
PMID: 15790531 [PubMed - indexed for MEDLINE]

449: Smeyne RJ, Jackson-Lewis V.
The MPTP model of Parkinson's disease.
Brain Res Mol Brain Res. 2005 Mar 24;134(1):57-66. Review.
PMID: 15790530 [PubMed - indexed for MEDLINE]

450: Sonntag KC, Simantov R, Isacson O.
Stem cells may reshape the prospect of Parkinson's disease therapy.
Brain Res Mol Brain Res. 2005 Mar 24;134(1):34-51. Review.
PMID: 15790528 [PubMed - indexed for MEDLINE]

451: Au WL, Adams JR, Troiano AR, Stoessl AJ.
Parkinson's disease: in vivo assessment of disease progression using positron
emission tomography.
Brain Res Mol Brain Res. 2005 Mar 24;134(1):24-33. Epub 2004 Nov 2. Review.
PMID: 15790527 [PubMed - indexed for MEDLINE]

452: Maguire-Zeiss KA, Short DW, Federoff HJ.
Synuclein, dopamine and oxidative stress: co-conspirators in Parkinson's disease?
Brain Res Mol Brain Res. 2005 Mar 24;134(1):18-23. Review.
PMID: 15790526 [PubMed - indexed for MEDLINE]

453: Lundvig D, Lindersson E, Jensen PH.
Pathogenic effects of alpha-synuclein aggregation.
Brain Res Mol Brain Res. 2005 Mar 24;134(1):3-17. Review.
PMID: 15790525 [PubMed - indexed for MEDLINE]

454: Chiang YH, Borlongan CV, Zhou FC, Hoffer BJ, Wang Y.
Transplantation of fetal kidney cells: neuroprotection and neuroregeneration.
Cell Transplant. 2005;14(1):1-9. Review.
PMID: 15789657 [PubMed - indexed for MEDLINE]

455: Lyytinen J, Kaakkola S.
[Will the mystery of Parkinson's disease be resolved?]
Duodecim. 2005;121(3):275-84. Review. Finnish. No abstract available.
PMID: 15787285 [PubMed - indexed for MEDLINE]

456: Fedorow H, Tribl F, Halliday G, Gerlach M, Riederer P, Double KL.
Neuromelanin in human dopamine neurons: comparison with peripheral melanins and
relevance to Parkinson's disease.
Prog Neurobiol. 2005 Feb;75(2):109-24. Review.
PMID: 15784302 [PubMed - indexed for MEDLINE]

457: O'Maley K, O'Sullivan J, Wollin J, Barras M, Brammer J.
Teaching people with Parkinson's disease about their medication.
Nurs Older People. 2005 Mar;17(1):14-6, 18, 20. Review.
PMID: 15782741 [PubMed - indexed for MEDLINE]

458: Kalenka A, Hinkelbein J.
[Anaesthesia in patients with Parkinson's disease]
Anaesthesist. 2005 Apr;54(4):401-9; quiz 410-1. Review. German.
PMID: 15778805 [PubMed - indexed for MEDLINE]

459: Gee JR, Keller JN.
Astrocytes: regulation of brain homeostasis via apolipoprotein E.
Int J Biochem Cell Biol. 2005 Jun;37(6):1145-50. Review.
PMID: 15778078 [PubMed - indexed for MEDLINE]

460: Czlonkowska A, Ciesielska A, Gromadzka G, Kurkowska-Jastrzebska I.
Estrogen and cytokines production - the possible cause of gender differences in
neurological diseases.
Curr Pharm Des. 2005;11(8):1017-30. Review.
PMID: 15777251 [PubMed - indexed for MEDLINE]

461: Nagatsu T, Sawada M.
Inflammatory process in Parkinson's disease: role for cytokines.
Curr Pharm Des. 2005;11(8):999-1016. Review.
PMID: 15777250 [PubMed - indexed for MEDLINE]

462: Barger SW, Moerman AM, Mao X.
Molecular mechanisms of cytokine-induced neuroprotection: NFkappaB and
neuroplasticity.
Curr Pharm Des. 2005;11(8):985-98. Review.
PMID: 15777249 [PubMed - indexed for MEDLINE]

463: Hayley S, Anisman H.
Multiple mechanisms of cytokine action in neurodegenerative and psychiatric
states: neurochemical and molecular substrates.
Curr Pharm Des. 2005;11(8):947-62. Review.
PMID: 15777246 [PubMed - indexed for MEDLINE]

464: Nyström T.
Role of oxidative carbonylation in protein quality control and senescence.
EMBO J. 2005 Apr 6;24(7):1311-7. Epub 2005 Mar 3. Review.
PMID: 15775985 [PubMed - indexed for MEDLINE]

465: Carrera E, Bogousslavsky J.
[Neurology]
Rev Med Suisse. 2005 Jan 5;1(1):44-50. Review. French.
PMID: 15773198 [PubMed - indexed for MEDLINE]

466: Plaza SM, Lamson DW.
Vitamin K2 in bone metabolism and osteoporosis.
Altern Med Rev. 2005 Mar;10(1):24-35. Review.
PMID: 15771560 [PubMed - indexed for MEDLINE]

467: Malchair P, Van Overmeire L, Boland A, Salmon E, Pierard L, Seutin V.
[Coenzyme Q10: biochemistry, pathophysiology of its deficiency and potential
benefit of an increased intake]
Rev Med Liege. 2005 Jan;60(1):45-51. Review. French.
PMID: 15771317 [PubMed - indexed for MEDLINE]

468: Benabid AL, Wallace B, Mitrofanis J, Xia C, Piallat B, Fraix V, Batir A,
Krack P, Pollak P, Berger F.
Therapeutic electrical stimulation of the central nervous system.
C R Biol. 2005 Feb;328(2):177-86. Review.
PMID: 15771004 [PubMed - indexed for MEDLINE]

469: Corti O, Hampe C, Darios F, Ibanez P, Ruberg M, Brice A.
Parkinson's disease: from causes to mechanisms.
C R Biol. 2005 Feb;328(2):131-42. Review.
PMID: 15770999 [PubMed - indexed for MEDLINE]

470: Eriksen JL, Wszolek Z, Petrucelli L.
Molecular pathogenesis of Parkinson disease.
Arch Neurol. 2005 Mar;62(3):353-7. Review.
PMID: 15767499 [PubMed - indexed for MEDLINE]

471: Jankovic J.
Progression of Parkinson disease: are we making progress in charting the course?
Arch Neurol. 2005 Mar;62(3):351-2. Review. No abstract available.
PMID: 15767498 [PubMed - indexed for MEDLINE]

472: Burke ZD, Tosh D.
Therapeutic potential of transdifferentiated cells.
Clin Sci (Lond). 2005 Apr;108(4):309-21. Review.
PMID: 15766332 [PubMed - indexed for MEDLINE]

473: Eriksen JL, Przedborski S, Petrucelli L.
Gene dosage and pathogenesis of Parkinson's disease.
Trends Mol Med. 2005 Mar;11(3):91-6. Review.
PMID: 15760766 [PubMed - indexed for MEDLINE]

474: Philips ST, Albin RL, Martin DM.
Genetics of subthalamic nucleus in development and disease.
Exp Neurol. 2005 Apr;192(2):320-30. Review.
PMID: 15755549 [PubMed - indexed for MEDLINE]

475: Koike Y, Frey MA, Sahiar F, Dodge R, Mohler S.
Effects of HZE particle on the nigrostriatal dopaminergic system in a future Mars
mission.
Acta Astronaut. 2005 Feb;56(3):367-78. Review.
PMID: 15754475 [PubMed - indexed for MEDLINE]

476: Kostrzewa RM, Nowak P, Kostrzewa JP, Kostrzewa RA, Brus R.
Peculiarities of L: -DOPA treatment of Parkinson's disease.
Amino Acids. 2005 Mar;28(2):157-64. Epub 2005 Mar 9. Review.
PMID: 15750845 [PubMed - indexed for MEDLINE]

477: Bailey CD, Tucholski J, Johnson GV.
Transglutaminases in neurodegenerative disorders.
Prog Exp Tumor Res. 2005;38:139-57. Review. No abstract available.
PMID: 15746534 [PubMed - indexed for MEDLINE]

478: Plowman BK, Boggie DT, Morreale AP, Schaefer MG, Delattre ML, Chan H.
Sleep attacks in patients receiving dopamine-receptor agonists.
Am J Health Syst Pharm. 2005 Mar 1;62(5):537-40. Review. No abstract available.
PMID: 15745920 [PubMed - indexed for MEDLINE]

479: Maingay M, Romero-Ramos M, Kirik D.
Viral vector mediated overexpression of human alpha-synuclein in the
nigrostriatal dopaminergic neurons: a new model for Parkinson's disease.
CNS Spectr. 2005 Mar;10(3):235-44. Review.
PMID: 15744224 [PubMed - indexed for MEDLINE]

480: Chinta SJ, Andersen JK.
Dopaminergic neurons.
Int J Biochem Cell Biol. 2005 May;37(5):942-6. Epub 2004 Dec 2. Review.
PMID: 15743669 [PubMed - indexed for MEDLINE]

481: Gibson BW.
The human mitochondrial proteome: oxidative stress, protein modifications and
oxidative phosphorylation.
Int J Biochem Cell Biol. 2005 May;37(5):927-34. Epub 2005 Jan 8. Review.
PMID: 15743667 [PubMed - indexed for MEDLINE]

482: Bennett MC.
The role of alpha-synuclein in neurodegenerative diseases.
Pharmacol Ther. 2005 Mar;105(3):311-31. Epub 2004 Dec 8. Review.
PMID: 15737408 [PubMed - indexed for MEDLINE]

483: Xu K, Bastia E, Schwarzschild M.
Therapeutic potential of adenosine A(2A) receptor antagonists in Parkinson's
disease.
Pharmacol Ther. 2005 Mar;105(3):267-310. Epub 2004 Dec 21. Review.
PMID: 15737407 [PubMed - indexed for MEDLINE]

484: Haacke EM, Cheng NY, House MJ, Liu Q, Neelavalli J, Ogg RJ, Khan A, Ayaz M,
Kirsch W, Obenaus A.
Imaging iron stores in the brain using magnetic resonance imaging.
Magn Reson Imaging. 2005 Jan;23(1):1-25. Review.
PMID: 15733784 [PubMed - indexed for MEDLINE]

485: Williams AC, Cartwright LS, Ramsden DB.
Parkinson's disease: the first common neurological disease due to
auto-intoxication?
QJM. 2005 Mar;98(3):215-26. Review.
PMID: 15728403 [PubMed - indexed for MEDLINE]

486: Simpkins JW, Wang J, Wang X, Perez E, Prokai L, Dykens JA.
Mitochondria play a central role in estrogen-induced neuroprotection.
Curr Drug Targets CNS Neurol Disord. 2005 Feb;4(1):69-83. Review.
PMID: 15723615 [PubMed - indexed for MEDLINE]

487: Kuan CY, Burke RE.
Targeting the JNK signaling pathway for stroke and Parkinson's diseases therapy.
Curr Drug Targets CNS Neurol Disord. 2005 Feb;4(1):63-7. Review.
PMID: 15723614 [PubMed - indexed for MEDLINE]

488: Duncan AJ, Heales SJ.
Nitric oxide and neurological disorders.
Mol Aspects Med. 2005 Feb-Apr;26(1-2):67-96. Epub 2005 Jan 24. Review.
PMID: 15722115 [PubMed - indexed for MEDLINE]

489: Borrelli E.
Without DJ-1, the D2 receptor doesn't play.
Neuron. 2005 Feb 17;45(4):479-81. Review.
PMID: 15721232 [PubMed - indexed for MEDLINE]

490: Kang D, Hamasaki N.
Alterations of mitochondrial DNA in common diseases and disease states: aging,
neurodegeneration, heart failure, diabetes, and cancer.
Curr Med Chem. 2005;12(4):429-41. Review.
PMID: 15720251 [PubMed - indexed for MEDLINE]

491: Silva RM, Kuan CY, Rakic P, Burke RE.
Mixed lineage kinase-c-jun N-terminal kinase signaling pathway: a new therapeutic
target in Parkinson's disease.
Mov Disord. 2005 Jun;20(6):653-64. Review.
PMID: 15719422 [PubMed - indexed for MEDLINE]

492: Pisani A, Centonze D, Bernardi G, Calabresi P.
Striatal synaptic plasticity: implications for motor learning and Parkinson's
disease.
Mov Disord. 2005 Apr;20(4):395-402. Review.
PMID: 15719415 [PubMed - indexed for MEDLINE]

493: Rickards H.
Depression in neurological disorders: Parkinson's disease, multiple sclerosis,
and stroke.
J Neurol Neurosurg Psychiatry. 2005 Mar;76 Suppl 1:i48-52. Review. No abstract
available.
PMID: 15718222 [PubMed - indexed for MEDLINE]

494: Pardridge WM.
Tyrosine hydroxylase replacement in experimental Parkinson's disease with
transvascular gene therapy.
NeuroRx. 2005 Jan;2(1):129-38. Review.
PMID: 15717064 [PubMed - indexed for MEDLINE]

495: Thanvi B, Lo N, Robinson T.
Vascular parkinsonism--an important cause of parkinsonism in older people.
Age Ageing. 2005 Mar;34(2):114-9. Review.
PMID: 15713855 [PubMed - indexed for MEDLINE]

496: Borges N.
Tolcapone in Parkinson's disease: liver toxicity and clinical efficacy.
Expert Opin Drug Saf. 2005 Jan;4(1):69-73. Review.
PMID: 15709899 [PubMed - indexed for MEDLINE]

497: Keating GM, Lyseng-Williamson KA.
Tolcapone: a review of its use in the management of Parkinson's disease.
CNS Drugs. 2005;19(2):165-84. Review.
PMID: 15697329 [PubMed - indexed for MEDLINE]

498: Fischman AJ.
Role of [18F]-dopa-PET imaging in assessing movement disorders.
Radiol Clin North Am. 2005 Jan;43(1):93-106. Review.
PMID: 15693650 [PubMed - indexed for MEDLINE]

499: Newberg AB, Alavi A.
The role of PET imaging in the management of patients with central nervous system
disorders.
Radiol Clin North Am. 2005 Jan;43(1):49-65. Review.
PMID: 15693647 [PubMed - indexed for MEDLINE]

500: Antunes F, Nunes C, Laranjinha J, Cadenas E.
Redox interactions of nitric oxide with dopamine and its derivatives.
Toxicology. 2005 Mar 15;208(2):207-12. Review.
PMID: 15691585 [PubMed - indexed for MEDLINE]

Back to top